false 2022 Q2 0001781755 12/31 0001781755 2022-01-01 2022-06-30 0001781755 us-gaap:CommonClassAMember 2022-08-03 xbrli:shares 0001781755 us-gaap:CommonClassBMember 2022-08-03 0001781755 2022-06-30 iso4217:USD 0001781755 2021-12-31 0001781755 us-gaap:CommonClassAMember 2021-12-31 iso4217:USD xbrli:shares 0001781755 us-gaap:CommonClassAMember 2022-06-30 0001781755 us-gaap:CommonClassBMember 2021-12-31 0001781755 us-gaap:CommonClassBMember 2022-06-30 0001781755 us-gaap:VariableInterestEntityPrimaryBeneficiaryMember 2022-06-30 0001781755 us-gaap:VariableInterestEntityPrimaryBeneficiaryMember 2021-12-31 0001781755 2022-04-01 2022-06-30 0001781755 2021-04-01 2021-06-30 0001781755 2021-01-01 2021-06-30 0001781755 us-gaap:CommonClassAMember us-gaap:CommonStockMember 2022-03-31 0001781755 us-gaap:CommonStockMember us-gaap:CommonClassBMember 2022-03-31 0001781755 us-gaap:AdditionalPaidInCapitalMember 2022-03-31 0001781755 us-gaap:RetainedEarningsMember 2022-03-31 0001781755 us-gaap:ReceivablesFromStockholderMember 2022-03-31 0001781755 us-gaap:NoncontrollingInterestMember 2022-03-31 0001781755 2022-03-31 0001781755 brp:RedeemableNoncontrollingInterestMember 2022-03-31 0001781755 us-gaap:RetainedEarningsMember 2022-04-01 2022-06-30 0001781755 us-gaap:NoncontrollingInterestMember 2022-04-01 2022-06-30 0001781755 brp:RedeemableNoncontrollingInterestMember 2022-04-01 2022-06-30 0001781755 us-gaap:CommonClassAMember us-gaap:CommonStockMember 2022-04-01 2022-06-30 0001781755 us-gaap:AdditionalPaidInCapitalMember 2022-04-01 2022-06-30 0001781755 us-gaap:CommonStockMember us-gaap:CommonClassBMember 2022-04-01 2022-06-30 0001781755 us-gaap:ReceivablesFromStockholderMember 2022-04-01 2022-06-30 0001781755 us-gaap:CommonClassAMember us-gaap:CommonStockMember 2022-06-30 0001781755 us-gaap:CommonStockMember us-gaap:CommonClassBMember 2022-06-30 0001781755 us-gaap:AdditionalPaidInCapitalMember 2022-06-30 0001781755 us-gaap:RetainedEarningsMember 2022-06-30 0001781755 us-gaap:ReceivablesFromStockholderMember 2022-06-30 0001781755 us-gaap:NoncontrollingInterestMember 2022-06-30 0001781755 brp:RedeemableNoncontrollingInterestMember 2022-06-30 0001781755 us-gaap:CommonClassAMember us-gaap:CommonStockMember 2021-12-31 0001781755 us-gaap:CommonStockMember us-gaap:CommonClassBMember 2021-12-31 0001781755 us-gaap:AdditionalPaidInCapitalMember 2021-12-31 0001781755 us-gaap:RetainedEarningsMember 2021-12-31 0001781755 us-gaap:ReceivablesFromStockholderMember 2021-12-31 0001781755 us-gaap:NoncontrollingInterestMember 2021-12-31 0001781755 brp:RedeemableNoncontrollingInterestMember 2021-12-31 0001781755 us-gaap:RetainedEarningsMember 2022-01-01 2022-06-30 0001781755 us-gaap:NoncontrollingInterestMember 2022-01-01 2022-06-30 0001781755 brp:RedeemableNoncontrollingInterestMember 2022-01-01 2022-06-30 0001781755 us-gaap:CommonClassAMember us-gaap:CommonStockMember 2022-01-01 2022-06-30 0001781755 us-gaap:AdditionalPaidInCapitalMember 2022-01-01 2022-06-30 0001781755 us-gaap:CommonStockMember us-gaap:CommonClassBMember 2022-01-01 2022-06-30 0001781755 us-gaap:ReceivablesFromStockholderMember 2022-01-01 2022-06-30 0001781755 us-gaap:CommonClassAMember us-gaap:CommonStockMember 2021-03-31 0001781755 us-gaap:CommonStockMember us-gaap:CommonClassBMember 2021-03-31 0001781755 us-gaap:AdditionalPaidInCapitalMember 2021-03-31 0001781755 us-gaap:RetainedEarningsMember 2021-03-31 0001781755 us-gaap:ReceivablesFromStockholderMember 2021-03-31 0001781755 us-gaap:NoncontrollingInterestMember 2021-03-31 0001781755 2021-03-31 0001781755 brp:RedeemableNoncontrollingInterestMember 2021-03-31 0001781755 us-gaap:RetainedEarningsMember 2021-04-01 2021-06-30 0001781755 us-gaap:NoncontrollingInterestMember 2021-04-01 2021-06-30 0001781755 brp:RedeemableNoncontrollingInterestMember 2021-04-01 2021-06-30 0001781755 us-gaap:CommonClassAMember us-gaap:CommonStockMember 2021-04-01 2021-06-30 0001781755 us-gaap:AdditionalPaidInCapitalMember 2021-04-01 2021-06-30 0001781755 us-gaap:CommonStockMember us-gaap:CommonClassBMember 2021-04-01 2021-06-30 0001781755 us-gaap:ReceivablesFromStockholderMember 2021-04-01 2021-06-30 0001781755 us-gaap:CommonClassAMember us-gaap:CommonStockMember 2021-06-30 0001781755 us-gaap:CommonStockMember us-gaap:CommonClassBMember 2021-06-30 0001781755 us-gaap:AdditionalPaidInCapitalMember 2021-06-30 0001781755 us-gaap:RetainedEarningsMember 2021-06-30 0001781755 us-gaap:ReceivablesFromStockholderMember 2021-06-30 0001781755 us-gaap:NoncontrollingInterestMember 2021-06-30 0001781755 2021-06-30 0001781755 brp:RedeemableNoncontrollingInterestMember 2021-06-30 0001781755 us-gaap:CommonClassAMember us-gaap:CommonStockMember 2020-12-31 0001781755 us-gaap:CommonStockMember us-gaap:CommonClassBMember 2020-12-31 0001781755 us-gaap:AdditionalPaidInCapitalMember 2020-12-31 0001781755 us-gaap:RetainedEarningsMember 2020-12-31 0001781755 us-gaap:ReceivablesFromStockholderMember 2020-12-31 0001781755 us-gaap:NoncontrollingInterestMember 2020-12-31 0001781755 2020-12-31 0001781755 brp:RedeemableNoncontrollingInterestMember 2020-12-31 0001781755 us-gaap:RetainedEarningsMember 2021-01-01 2021-06-30 0001781755 us-gaap:NoncontrollingInterestMember 2021-01-01 2021-06-30 0001781755 brp:RedeemableNoncontrollingInterestMember 2021-01-01 2021-06-30 0001781755 us-gaap:CommonClassAMember us-gaap:CommonStockMember 2021-01-01 2021-06-30 0001781755 us-gaap:AdditionalPaidInCapitalMember 2021-01-01 2021-06-30 0001781755 us-gaap:CommonStockMember us-gaap:CommonClassBMember 2021-01-01 2021-06-30 0001781755 us-gaap:ReceivablesFromStockholderMember 2021-01-01 2021-06-30 0001781755 srt:RevisionOfPriorPeriodErrorCorrectionAdjustmentMember 2022-04-01 2022-06-30 0001781755 srt:ScenarioPreviouslyReportedMember 2021-04-01 2021-06-30 0001781755 srt:RevisionOfPriorPeriodAccountingStandardsUpdateAdjustmentMember 2021-04-01 2021-06-30 0001781755 srt:ScenarioPreviouslyReportedMember 2021-01-01 2021-06-30 0001781755 srt:RevisionOfPriorPeriodAccountingStandardsUpdateAdjustmentMember 2021-01-01 2021-06-30 0001781755 2020-04-01 2020-04-01 brp:numberOfBusinessCombinations 0001781755 brp:WestwoodInsuranceAgencyMember 2022-04-29 2022-04-29 0001781755 brp:VentureCaptiveManagementLLCMember 2022-06-03 2022-06-03 0001781755 brp:WestwoodInsuranceAgencyMember 2022-01-01 2022-06-30 0001781755 brp:VentureCaptiveManagementLLCMember 2022-01-01 2022-06-30 0001781755 brp:WestwoodInsuranceAgencyMember 2022-06-30 0001781755 brp:VentureCaptiveManagementLLCMember 2022-06-30 0001781755 brp:LeaseTrackRogersGrayFounderShieldTheCapitalGroupRiverOakRiskAndSeriesOfIndividuallyImmaterialBusinessAcquisitionsMember 2022-06-30 0001781755 us-gaap:CustomerRelationshipsMember 2022-06-30 0001781755 us-gaap:CustomerRelationshipsMember 2022-01-01 2022-06-30 0001781755 brp:DistributorRelationshipsMember 2022-06-30 0001781755 brp:DistributorRelationshipsMember 2022-01-01 2022-06-30 0001781755 us-gaap:ComputerSoftwareIntangibleAssetMember 2022-06-30 0001781755 us-gaap:ComputerSoftwareIntangibleAssetMember 2022-01-01 2022-06-30 0001781755 us-gaap:TradeNamesMember 2022-06-30 0001781755 us-gaap:TradeNamesMember 2022-01-01 2022-06-30 0001781755 us-gaap:VariableInterestEntityPrimaryBeneficiaryMember 2022-04-01 2022-06-30 0001781755 us-gaap:VariableInterestEntityPrimaryBeneficiaryMember 2021-04-01 2021-06-30 0001781755 us-gaap:VariableInterestEntityPrimaryBeneficiaryMember 2022-01-01 2022-06-30 0001781755 us-gaap:VariableInterestEntityPrimaryBeneficiaryMember 2021-01-01 2021-06-30 0001781755 brp:DirectBillRevenueMember 2022-04-01 2022-06-30 0001781755 brp:DirectBillRevenueMember 2021-04-01 2021-06-30 0001781755 brp:DirectBillRevenueMember 2022-01-01 2022-06-30 0001781755 brp:DirectBillRevenueMember 2021-01-01 2021-06-30 0001781755 brp:AgencyBillRevenueMember 2022-04-01 2022-06-30 0001781755 brp:AgencyBillRevenueMember 2021-04-01 2021-06-30 0001781755 brp:AgencyBillRevenueMember 2022-01-01 2022-06-30 0001781755 brp:AgencyBillRevenueMember 2021-01-01 2021-06-30 0001781755 brp:ProfitSharingRevenueMember 2022-04-01 2022-06-30 0001781755 brp:ProfitSharingRevenueMember 2021-04-01 2021-06-30 0001781755 brp:ProfitSharingRevenueMember 2022-01-01 2022-06-30 0001781755 brp:ProfitSharingRevenueMember 2021-01-01 2021-06-30 0001781755 brp:ConsultingandServiceFeeRevenueMember 2022-04-01 2022-06-30 0001781755 brp:ConsultingandServiceFeeRevenueMember 2021-04-01 2021-06-30 0001781755 brp:ConsultingandServiceFeeRevenueMember 2022-01-01 2022-06-30 0001781755 brp:ConsultingandServiceFeeRevenueMember 2021-01-01 2021-06-30 0001781755 brp:PolicyFeeandInstallmentFeeRevenueMember 2022-04-01 2022-06-30 0001781755 brp:PolicyFeeandInstallmentFeeRevenueMember 2021-04-01 2021-06-30 0001781755 brp:PolicyFeeandInstallmentFeeRevenueMember 2022-01-01 2022-06-30 0001781755 brp:PolicyFeeandInstallmentFeeRevenueMember 2021-01-01 2021-06-30 0001781755 us-gaap:OtherInsuranceProductLineMember 2022-04-01 2022-06-30 0001781755 us-gaap:OtherInsuranceProductLineMember 2021-04-01 2021-06-30 0001781755 us-gaap:OtherInsuranceProductLineMember 2022-01-01 2022-06-30 0001781755 us-gaap:OtherInsuranceProductLineMember 2021-01-01 2021-06-30 0001781755 us-gaap:CustomerRelationshipsMember 2021-12-31 0001781755 brp:DistributorRelationshipsMember 2021-12-31 0001781755 us-gaap:ComputerSoftwareIntangibleAssetMember 2021-12-31 0001781755 us-gaap:TradeNamesMember 2021-12-31 0001781755 brp:InsuranceCarrierRelationshipsMember 2022-06-30 0001781755 brp:InsuranceCarrierRelationshipsMember 2021-12-31 0001781755 brp:MiddleMarketSegmentMember 2021-12-31 0001781755 brp:SpecialtySegmentMember 2021-12-31 0001781755 brp:MainstreetSegmentMember 2021-12-31 0001781755 brp:MedicareSegmentMember 2021-12-31 0001781755 brp:MiddleMarketSegmentMember 2022-01-01 2022-06-30 0001781755 brp:SpecialtySegmentMember 2022-01-01 2022-06-30 0001781755 brp:MainstreetSegmentMember 2022-01-01 2022-06-30 0001781755 brp:MedicareSegmentMember 2022-01-01 2022-06-30 0001781755 brp:MiddleMarketSegmentMember 2022-06-30 0001781755 brp:SpecialtySegmentMember 2022-06-30 0001781755 brp:MainstreetSegmentMember 2022-06-30 0001781755 brp:MedicareSegmentMember 2022-06-30 0001781755 us-gaap:AccountsPayableMember 2022-01-01 2022-06-30 0001781755 us-gaap:SubsequentEventMember 2022-07-01 2022-08-09 0001781755 brp:CreditAgreementOctober2020Member us-gaap:LineOfCreditMember brp:JPMorganChaseBankNAMember 2021-12-31 0001781755 us-gaap:MediumTermNotesMember us-gaap:SecuredDebtMember brp:CreditAgreementOctober2020Member brp:JPMorganChaseBankNAMember 2021-12-31 0001781755 brp:CreditAgreementOctober2020Member us-gaap:LineOfCreditMember brp:JPMorganChaseBankNAMember us-gaap:RevolvingCreditFacilityMember 2021-12-31 0001781755 us-gaap:LineOfCreditMember brp:CreditAgreementAmendmentNo5March2022Member brp:JPMorganChaseBankNAMember us-gaap:RevolvingCreditFacilityMember 2022-03-28 0001781755 us-gaap:LineOfCreditMember brp:SecuredOvernightFinancingRateMember brp:CreditAgreementAmendmentNo5March2022Member brp:JPMorganChaseBankNAMember us-gaap:RevolvingCreditFacilityMember 2022-03-28 2022-03-28 xbrli:pure 0001781755 us-gaap:LineOfCreditMember brp:SecuredOvernightFinancingRateMember srt:MinimumMember brp:CreditAgreementAmendmentNo5March2022Member brp:JPMorganChaseBankNAMember us-gaap:RevolvingCreditFacilityMember 2022-03-28 2022-03-28 0001781755 us-gaap:LineOfCreditMember srt:MaximumMember brp:SecuredOvernightFinancingRateMember brp:CreditAgreementAmendmentNo5March2022Member brp:JPMorganChaseBankNAMember us-gaap:RevolvingCreditFacilityMember 2022-03-28 2022-03-28 0001781755 us-gaap:LondonInterbankOfferedRateLIBORMember us-gaap:MediumTermNotesMember us-gaap:SecuredDebtMember brp:CreditAgreementOctober2020Member brp:JPMorganChaseBankNAMember 2022-01-01 2022-06-30 0001781755 us-gaap:LondonInterbankOfferedRateLIBORMember us-gaap:MediumTermNotesMember us-gaap:SecuredDebtMember brp:CreditAgreementAmendmentNo2June2021Member brp:JPMorganChaseBankNAMember 2022-01-01 2022-06-30 0001781755 us-gaap:MediumTermNotesMember us-gaap:SecuredDebtMember brp:CreditAgreementOctober2020Member brp:JPMorganChaseBankNAMember 2022-06-30 0001781755 us-gaap:MediumTermNotesMember us-gaap:SecuredDebtMember brp:CreditAgreementOctober2020Member brp:JPMorganChaseBankNAMember 2022-06-30 2022-06-30 0001781755 us-gaap:LineOfCreditMember brp:CreditAgreementAmendmentNo5March2022Member brp:JPMorganChaseBankNAMember us-gaap:RevolvingCreditFacilityMember 2022-06-30 0001781755 us-gaap:LineOfCreditMember brp:CreditAgreementAmendmentNo5March2022Member brp:JPMorganChaseBankNAMember us-gaap:RevolvingCreditFacilityMember 2022-06-30 2022-06-30 0001781755 brp:InterestRateCapExpirationMarch2026Member 2022-05-05 0001781755 brp:InterestRateCapExpirationMarch2026Member us-gaap:LondonInterbankOfferedRateLIBORMember 2022-05-05 0001781755 brp:InterestRateCapExpirationAugust2028OneMember 2022-05-05 0001781755 brp:InterestRateCapExpirationAugust2028Member 2022-05-05 0001781755 us-gaap:LondonInterbankOfferedRateLIBORMember brp:InterestRateCapExpirationAugust2028OneMember 2022-05-05 0001781755 us-gaap:LondonInterbankOfferedRateLIBORMember brp:InterestRateCapExpirationAugust2028Member 2022-05-05 0001781755 us-gaap:InterestRateCapMember 2022-05-05 2022-05-05 0001781755 brp:InterestRateCapExpirationMarch2024Member 2022-05-05 0001781755 us-gaap:LondonInterbankOfferedRateLIBORMember brp:InterestRateCapExpirationMarch2024Member 2022-05-05 0001781755 us-gaap:InterestRateCapMember 2022-06-30 0001781755 us-gaap:InterestRateCapMember 2021-12-31 0001781755 us-gaap:InterestRateCapMember 2022-04-01 2022-06-30 0001781755 us-gaap:InterestRateCapMember 2022-01-01 2022-06-30 0001781755 us-gaap:InterestRateCapMember 2021-01-01 2021-06-30 0001781755 us-gaap:InterestRateCapMember 2021-04-01 2021-06-30 0001781755 brp:VillagesBrokerCommissionsMember 2022-04-01 2022-06-30 0001781755 brp:VillagesBrokerCommissionsMember 2021-04-01 2021-06-30 0001781755 brp:VillagesBrokerCommissionsMember 2022-01-01 2022-06-30 0001781755 brp:VillagesBrokerCommissionsMember 2021-01-01 2021-06-30 0001781755 brp:DirectorBrokerCommissionsMember 2022-04-01 2022-06-30 0001781755 brp:DirectorBrokerCommissionsMember 2022-01-01 2022-06-30 0001781755 brp:RiskAdvisorCommissionOneMember 2022-04-01 2022-06-30 0001781755 brp:RiskAdvisorCommissionOneMember 2021-04-01 2021-06-30 0001781755 brp:RiskAdvisorCommissionOneMember 2021-01-01 2021-06-30 0001781755 brp:RiskAdvisorCommissionOneMember 2022-01-01 2022-06-30 0001781755 brp:VillagesLeasedFacilitiesMember 2022-04-01 2022-06-30 0001781755 brp:VillagesLeasedFacilitiesMember 2021-04-01 2021-06-30 0001781755 brp:VillagesLeasedFacilitiesMember 2022-01-01 2022-06-30 0001781755 brp:VillagesLeasedFacilitiesMember 2021-01-01 2021-06-30 0001781755 brp:OtherRelatedPartiesLeasedFacilitiesMember 2022-04-01 2022-06-30 0001781755 brp:OtherRelatedPartiesLeasedFacilitiesMember 2021-04-01 2021-06-30 0001781755 brp:OtherRelatedPartiesLeasedFacilitiesMember 2022-01-01 2022-06-30 0001781755 brp:OtherRelatedPartiesLeasedFacilitiesMember 2021-01-01 2021-06-30 0001781755 brp:OtherRelatedPartiesLeasedFacilitiesMember 2022-06-30 0001781755 brp:OtherRelatedPartiesLeasedFacilitiesMember 2021-12-31 0001781755 us-gaap:CommonClassAMember brp:BRPGroupInc.OmnibusIncentivePlanMember 2022-06-30 0001781755 brp:BRPGroupIncPartnershipInducementAwardPlanMember us-gaap:CommonClassAMember 2022-06-30 0001781755 brp:ShareBasedPaymentArrangementCliffVestingMember srt:MinimumMember brp:BRPGroupIncOmnibusIncentiveAndPartnershipInducementAwardPlansMember 2022-01-01 2022-06-30 0001781755 srt:MaximumMember brp:ShareBasedPaymentArrangementCliffVestingMember brp:BRPGroupIncOmnibusIncentiveAndPartnershipInducementAwardPlansMember 2022-01-01 2022-06-30 0001781755 brp:ShareBasedPaymentArrangementRatableVestingMember srt:MinimumMember brp:BRPGroupIncOmnibusIncentiveAndPartnershipInducementAwardPlansMember 2022-01-01 2022-06-30 0001781755 brp:ShareBasedPaymentArrangementRatableVestingMember srt:MaximumMember brp:BRPGroupIncOmnibusIncentiveAndPartnershipInducementAwardPlansMember 2022-01-01 2022-06-30 0001781755 us-gaap:RestrictedStockMember 2022-01-01 2022-06-30 0001781755 us-gaap:RestrictedStockMember 2021-01-01 2021-06-30 0001781755 us-gaap:RestrictedStockMember 2022-04-01 2022-06-30 0001781755 us-gaap:RestrictedStockMember 2021-04-01 2021-06-30 0001781755 us-gaap:RestrictedStockMember 2022-01-01 2022-06-30 0001781755 us-gaap:RestrictedStockMember 2021-01-01 2021-06-30 0001781755 us-gaap:EquityUnitPurchaseAgreementsMember 2022-04-01 2022-06-30 0001781755 us-gaap:EquityUnitPurchaseAgreementsMember 2021-04-01 2021-06-30 0001781755 us-gaap:EquityUnitPurchaseAgreementsMember 2022-01-01 2022-06-30 0001781755 us-gaap:EquityUnitPurchaseAgreementsMember 2021-01-01 2021-06-30 0001781755 us-gaap:FairValueMeasurementsRecurringMember us-gaap:FairValueInputsLevel2Member 2022-06-30 0001781755 us-gaap:FairValueMeasurementsRecurringMember us-gaap:FairValueInputsLevel2Member 2021-12-31 0001781755 us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember 2022-06-30 0001781755 us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember 2021-12-31 0001781755 us-gaap:FairValueMeasurementsRecurringMember 2022-06-30 0001781755 srt:MinimumMember brp:MeasurementInputRevenueorEBITDAGrowthRateMember 2022-06-30 0001781755 srt:MaximumMember brp:MeasurementInputRevenueorEBITDAGrowthRateMember 2022-06-30 0001781755 srt:MinimumMember brp:MeasurementInputRevenueorEBITDAGrowthRateMember 2021-12-31 0001781755 srt:MaximumMember brp:MeasurementInputRevenueorEBITDAGrowthRateMember 2021-12-31 0001781755 us-gaap:MeasurementInputDiscountRateMember srt:MinimumMember 2022-06-30 0001781755 us-gaap:MeasurementInputDiscountRateMember srt:MaximumMember 2022-06-30 0001781755 us-gaap:MeasurementInputDiscountRateMember srt:MinimumMember 2021-12-31 0001781755 us-gaap:MeasurementInputDiscountRateMember srt:MaximumMember 2021-12-31 0001781755 brp:ContingentEarnoutLiabilitiesMember 2022-03-31 0001781755 brp:ContingentEarnoutLiabilitiesMember 2021-03-31 0001781755 brp:ContingentEarnoutLiabilitiesMember 2021-12-31 0001781755 brp:ContingentEarnoutLiabilitiesMember 2020-12-31 0001781755 brp:ContingentEarnoutLiabilitiesMember 2022-04-01 2022-06-30 0001781755 brp:ContingentEarnoutLiabilitiesMember 2021-04-01 2021-06-30 0001781755 brp:ContingentEarnoutLiabilitiesMember 2022-01-01 2022-06-30 0001781755 brp:ContingentEarnoutLiabilitiesMember 2021-01-01 2021-06-30 0001781755 brp:ContingentEarnoutLiabilitiesMember 2022-06-30 0001781755 brp:ContingentEarnoutLiabilitiesMember 2021-06-30 0001781755 us-gaap:CarryingReportedAmountFairValueDisclosureMember 2022-06-30 0001781755 us-gaap:EstimateOfFairValueFairValueDisclosureMember 2022-06-30 0001781755 us-gaap:CarryingReportedAmountFairValueDisclosureMember 2021-12-31 0001781755 us-gaap:EstimateOfFairValueFairValueDisclosureMember 2021-12-31 0001781755 2022-04-30 brp:segment 0001781755 brp:MiddleMarketSegmentMember 2022-04-01 2022-06-30 0001781755 brp:SpecialtySegmentMember 2022-04-01 2022-06-30 0001781755 brp:MainstreetSegmentMember 2022-04-01 2022-06-30 0001781755 brp:MedicareSegmentMember 2022-04-01 2022-06-30 0001781755 us-gaap:CorporateAndOtherMember 2022-04-01 2022-06-30 0001781755 brp:MiddleMarketSegmentMember 2021-04-01 2021-06-30 0001781755 brp:SpecialtySegmentMember 2021-04-01 2021-06-30 0001781755 brp:MainstreetSegmentMember 2021-04-01 2021-06-30 0001781755 brp:MedicareSegmentMember 2021-04-01 2021-06-30 0001781755 us-gaap:CorporateAndOtherMember 2021-04-01 2021-06-30 0001781755 us-gaap:CorporateAndOtherMember 2022-01-01 2022-06-30 0001781755 brp:MiddleMarketSegmentMember 2021-01-01 2021-06-30 0001781755 brp:SpecialtySegmentMember 2021-01-01 2021-06-30 0001781755 brp:MainstreetSegmentMember 2021-01-01 2021-06-30 0001781755 brp:MedicareSegmentMember 2021-01-01 2021-06-30 0001781755 us-gaap:CorporateAndOtherMember 2021-01-01 2021-06-30 0001781755 us-gaap:IntersegmentEliminationMember brp:MiddleMarketSegmentMember 2022-04-01 2022-06-30 0001781755 us-gaap:IntersegmentEliminationMember brp:MiddleMarketSegmentMember 2022-01-01 2022-06-30 0001781755 us-gaap:IntersegmentEliminationMember brp:SpecialtySegmentMember 2022-04-01 2022-06-30 0001781755 us-gaap:IntersegmentEliminationMember brp:SpecialtySegmentMember 2022-01-01 2022-06-30 0001781755 brp:MainstreetSegmentMember us-gaap:IntersegmentEliminationMember 2022-04-01 2022-06-30 0001781755 brp:MainstreetSegmentMember us-gaap:IntersegmentEliminationMember 2022-01-01 2022-06-30 0001781755 us-gaap:IntersegmentEliminationMember brp:MedicareSegmentMember 2022-04-01 2022-06-30 0001781755 us-gaap:IntersegmentEliminationMember brp:MedicareSegmentMember 2022-01-01 2022-06-30 0001781755 us-gaap:IntersegmentEliminationMember brp:MiddleMarketSegmentMember 2021-04-01 2021-06-30 0001781755 us-gaap:IntersegmentEliminationMember brp:MiddleMarketSegmentMember 2021-01-01 2021-06-30 0001781755 brp:MainstreetSegmentMember us-gaap:IntersegmentEliminationMember 2021-04-01 2021-06-30 0001781755 brp:MainstreetSegmentMember us-gaap:IntersegmentEliminationMember 2021-01-01 2021-06-30 0001781755 us-gaap:IntersegmentEliminationMember brp:MedicareSegmentMember 2021-04-01 2021-06-30 0001781755 us-gaap:IntersegmentEliminationMember brp:MedicareSegmentMember 2021-01-01 2021-06-30 0001781755 us-gaap:CorporateAndOtherMember 2022-06-30 0001781755 us-gaap:CorporateAndOtherMember 2021-12-31 0001781755 brp:NationalHealthPlansBenefitsAgencyLLCMember us-gaap:SubsequentEventMember 2022-08-01 2022-08-01
_____________________________________________________________________________________________
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
______________________________
FORM 10-Q
______________________________
(Mark One)

☒ | Quarterly report pursuant to section 13 or 15(d) of the Securities Exchange Act of 1934

For the quarterly period ended June 30, 2022
or

☐ | Transition report pursuant to section 13 or 15(d) of the Securities Exchange Act of 1934

For the transition period from ________ to _________
Commission File Number: 001-39095
______________________________
BRP GROUP, INC.
(Exact name of registrant as specified in its charter)
______________________________

| Delaware |  |  |  | 61-1937225 |
| (State or other jurisdiction of |  |  | (I.R.S. Employer |
| incorporation or organization) |  |  | Identification No.) |

4211 W. Boy Scout Blvd., Suite 800, Tampa, Florida 33607
(Address of principal executive offices) (Zip Code)
(866) 279-0698
(Registrant’s telephone number, including area code)
Not Applicable
(Former Name, former address and former fiscal year, if changed since last report)
Securities registered pursuant to Section 12(b) of the Act:

Title of each class |  | Trading Symbol(s) |  | Name of each exchange on which registered
Class A Common Stock, par value $0.01 per share |  | BRP |  | Nasdaq Global Select Market

______________________________
Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes x No o
Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§ 232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). Yes x No o
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company” and “emerging growth company” in Rule 12b-2 of the Exchange Act.

Large accelerated filer | x |  | Accelerated filer | o
Non-accelerated filer | o |  | Smaller reporting company | o
|  |  | Emerging growth company | o

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. o
Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes o No x
As of August 3, 2022, there were 60,245,239 shares of Class A common stock outstanding and 55,471,865 shares of Class B common stock outstanding.

BRP GROUP, INC.
INDEX

|  |  |  | Page
PART I. FINANCIAL INFORMATION |  |
| ITEM 1. | Financial Statements (Unaudited) |  |
|  | Condensed Consolidated Balance Sheets as of J une 30, 2022 and December 31, 2021 |  | 5
|  | Condensed Consolidated Statements of Comprehensive Income (Loss) for the Three and Six Months Ended June 30, 2022 and 2021 |  | 7
|  | Condensed Consolidated Statements of Stockholders’ Equity and Mezzanine Equity for the Three and Si x Months Ended June 30, 2022 and 2021 |  | 8
|  | Condensed Consolidated Statements of Cash Flows for the Six Months Ended June 30 2022 and 2021 |  | 10
|  | Notes to Condensed Consolidated Financial Statements |  | 12
| ITEM 2. | Management’s Discussion and Analysis of Financial Condition and Results of Operations |  | 27
| ITEM 3. | Quantitative and Qualitative Disclosures about Market Risk |  | 42
| ITEM 4. | Controls and Procedures |  | 43
PART II. OTHER INFORMATION |  | 43
| ITEM 1. | Legal Proceedings |  | 43
| ITEM 1A. | Risk Factors |  | 44
| ITEM 2. | Unregistered Sales of Equity Securities and Use of Proceeds |  | 44
| ITEM 3. | Defaults Upon Senior Securities |  | 44
| ITEM 4. | Mine Safety Disclosures |  | 44
| ITEM 5. | Other Information |  | 44
| ITEM 6. | Exhibits |  | 45
SIGNATURES |  | 46

Note Regarding Forward-Looking Statements
We have made statements in this report, including matters discussed under Part I, Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations, Part II, Item 1. Legal Proceedings, Part II, Item 1A. Risk Factors and in other sections of this report, that are forward-looking statements. In some cases, you can identify these statements by forward-looking words such as “may,” “might,” “will,” “should,” “expects,” “plans,” “anticipates,” “believes,” “estimates,” “predicts,” “potential” or “continue,” the negative of these terms and other comparable terminology. These forward-looking statements, which are subject to risks, uncertainties and assumptions about us, may include projections of our future financial performance, our anticipated growth strategies and anticipated trends in our business. These statements are only predictions based on our current expectations and projections about future events. There are important factors that could cause our actual results, level of activity, performance or achievements to differ materially from the results, level of activity, performance or achievements expressed or implied by the forward-looking statements, including those factors discussed under Part II, Item 1A. Risk Factors. You should specifically consider the numerous risks outlined under Part I, Item 1A. Risk Factors in our Annual Report on Form 10-K filed with the SEC on March 1, 2022.
Although we believe the expectations reflected in the forward-looking statements are reasonable, we cannot guarantee future results, level of activity, performance or achievements. Moreover, neither we nor any other person assumes responsibility for the accuracy and completeness of any of these forward-looking statements. We are under no duty to update any of these forward-looking statements after the date of this report to conform our prior statements to actual results or revised expectations, except as required by law.

Commonly Used Defined Terms
The following terms have the following meanings throughout this Quarterly Report on Form 10-Q unless the context indicates or requires otherwise:

Amended LLC Agreement |  | Third Amended and Restated Limited Liability Company Agreement of Baldwin Risk Partners, LLC, as amended
Book of Business |  | Insurance policies bound by us on behalf of our Clients
bps |  | Basis points
Clients |  | Our insureds
Colleagues |  | Our employees
Exchange Act |  | Securities Exchange Act of 1934, as amended
Insurance Company Partners |  | Insurance companies with which we have a contractual relationship
JPM Credit Agreement |  | Credit Agreement, dated as of October 14, 2020, between Baldwin Risk Partners, LLC, as borrower, JPMorgan Chase Bank, N.A., as the Administrative Agent, the Guarantors party thereto, the Lenders party thereto and the Issuing Lenders party thereto, as amended by the Amendment No. 1 to Credit Agreement dated as of May 7, 2021, Amendment No. 2 to Credit Agreement dated as of June 2, 2021, Amendment No. 3 to Credit Agreement dated as of August 6, 2021, Amendment No. 4 to Credit Agreement dated as of December 16, 2021 and Amendment No. 5 to Credit Agreement dated as of March 28, 2022
LIBOR |  | London Interbank Offered Rate
MGA |  | Managing General Agent
MSI |  | Millennial Specialty Insurance, a 2019 Partner
Operating Groups |  | Our reportable segments
Partners |  | Companies that we have acquired, or in the case of asset acquisitions, the producers
Partnerships |  | Strategic acquisitions made by the Company
Risk Advisors |  | Our producers
SEC |  | U.S. Securities and Exchange Commission
Securities Act |  | Securities Act of 1933, as amended
SOFR |  | Secured Overnight Financing Rate
Tax Receivable Agreement |  | Tax Receivable Agreement between BRP Group, Inc. and the holders of LLC Units in Baldwin Risk Partners, LLC entered into on October 28, 2019

PART I. FINANCIAL INFORMATION
ITEM 1. FINANCIAL STATEMENTS
BRP GROUP, INC.
Condensed Consolidated Balance Sheets
(Unaudited)

(in thousands, except share and per share data) |  | June 30, 2022 |  | December 31, 2021
Assets |  |  |  |
Current assets: |  |  |  |
Cash and cash equivalents |  | $ | 183,402 |  |  | $ | 138,292 |
Restricted cash |  | 100,529 |  |  | 89,445 |
Premiums, commissions and fees receivable, net |  | 427,351 |  |  | 340,837 |
Prepaid expenses and other current assets |  | 13,533 |  |  | 8,151 |
Due from related parties |  | 1,715 |  |  | 1,668 |
Total current assets |  | 726,530 |  |  | 578,393 |
Property and equipment, net |  | 22,756 |  |  | 17,474 |
Right-of-use assets |  | 86,374 |  |  | 81,646 |
Other assets |  | 34,316 |  |  | 25,586 |
Intangible assets, net |  | 1,125,388 |  |  | 944,467 |
Goodwill |  | 1,415,281 |  |  | 1,228,741 |
Total assets |  | $ | 3,410,645 |  |  | $ | 2,876,307 |
Liabilities, Mezzanine Equity and Stockholders’ Equity |  |  |  |
Current liabilities: |  |  |  |
Premiums payable to insurance companies |  | $ | 366,217 |  |  | $ | 310,045 |
Producer commissions payable |  | 56,138 |  |  | 41,833 |
Accrued expenses and other current liabilities |  | 104,330 |  |  | 92,223 |
Related party notes payable |  | — |  |  | 61,500 |
Current portion of contingent earnout liabilities |  | 43,615 |  |  | 35,088 |
Total current liabilities |  | 570,300 |  |  | 540,689 |
Revolving line of credit |  | 525,000 |  |  | 35,000 |
Long-term debt, less current portion |  | 812,080 |  |  | 814,614 |
Contingent earnout liabilities, less current portion |  | 166,381 |  |  | 223,501 |
Operating lease liabilities, less current portion |  | 76,999 |  |  | 71,357 |
Other liabilities |  | — |  |  | 3,590 |
Total liabilities |  | 2,150,760 |  |  | 1,688,751 |
Commitments and contingencies (Note 14) |  |  |  |
Mezzanine equity: |  |  |  |
Redeemable noncontrolling interest |  | 350 |  |  | 269 |
Stockholders’ equity: |  |  |  |
Class A common stock, par value $0.01 per share, 300,000,000 shares authorized; 60,122,842 and 58,602,859 shares issued and outstanding at June 30, 2022 and December 31, 2021, respectively |  | 601 |  |  | 586 |
Class B common stock, par value $0.0001 per share, 100,000,000 shares authorized; 55,442,435 and 56,338,051 shares issued and outstanding at June 30, 2022 and December 31, 2021, respectively |  | 6 |  |  | 6 |
Additional paid-in capital |  | 683,331 |  |  | 663,002 |
Accumulated deficit |  | (23,481) |  |  | (54,992) |
Stockholder notes receivable |  | (131) |  |  | (219) |
Total stockholders’ equity attributable to BRP Group, Inc. |  | 660,326 |  |  | 608,383 |
Noncontrolling interest |  | 599,209 |  |  | 578,904 |
Total stockholders’ equity |  | 1,259,535 |  |  | 1,187,287 |
Total liabilities, mezzanine equity and stockholders’ equity |  | $ | 3,410,645 |  |  | $ | 2,876,307 |

See accompanying Notes to Condensed Consolidated Financial Statements. 5

BRP GROUP, INC.
Condensed Consolidated Balance Sheets (Continued)
(Unaudited)
The following table presents the assets and liabilities of the Company’s consolidated variable interest entities, which are included on the condensed consolidated balance sheets above. The assets in the table below include those assets that can only be used to settle obligations of the consolidated variable interest entities.

(in thousands) |  | June 30, 2022 |  | December 31, 2021
Assets of Consolidated Variable Interest Entities That Can Only be Used to Settle the Obligations of Consolidated Variable Interest Entities: |  |  |  |
Cash and cash equivalents |  | $ | 195 |  |  | $ | 303 |
Premiums, commissions and fees receivable, net |  | 337 |  |  | 272 |
Total current assets |  | 532 |  |  | 575 |
Property and equipment, net |  | 12 |  |  | 15 |
Other assets |  | 5 |  |  | 5 |
Total assets |  | $ | 549 |  |  | $ | 595 |
Liabilities of Consolidated Variable Interest Entities for Which Creditors Do Not Have Recourse to the Company: |  |  |  |
Premiums payable to insurance companies |  | $ | 39 |  |  | $ | — |
Producer commissions payable |  | 46 |  |  | 41 |
Accrued expenses and other current liabilities |  | 11 |  |  | 4 |
Total liabilities |  | $ | 96 |  |  | $ | 45 |

See accompanying Notes to Condensed Consolidated Financial Statements. 6

BRP GROUP, INC.
Condensed Consolidated Statements of Comprehensive Income (Loss)
(Unaudited)

|  | For the Three Months Ended June 30, |  | For the Six Months Ended June 30,
(in thousands, except share and per share data) |  | 2022 |  | 2021 |  | 2022 |  | 2021
Revenues: |  |  |  |  |  |  |  |
Commissions and fees |  | $ | 232,460 |  |  | $ | 119,706 |  |  | $ | 475,308 |  |  | $ | 272,534 |
Operating expenses: |  |  |  |  |  |  |  |
Commissions, employee compensation and benefits |  | 172,848 |  |  | 89,065 |  |  | 326,598 |  |  | 178,440 |
Other operating expenses |  | 40,770 |  |  | 19,537 |  |  | 77,212 |  |  | 36,412 |
Amortization expense |  | 19,170 |  |  | 10,742 |  |  | 36,732 |  |  | 21,279 |
Change in fair value of contingent consideration |  | (26,872) |  |  | 13,325 |  |  | (32,504) |  |  | 11,822 |
Depreciation expense |  | 1,105 |  |  | 573 |  |  | 2,093 |  |  | 1,167 |
Total operating expenses |  | 207,021 |  |  | 133,242 |  |  | 410,131 |  |  | 249,120 |
Operating income (loss) |  | 25,439 |  |  | (13,536) |  |  | 65,177 |  |  | 23,414 |
Other income (expense): |  |  |  |  |  |  |  |
Interest expense, net |  | (14,632) |  |  | (5,848) |  |  | (24,982) |  |  | (11,491) |
Other income (expense), net |  | 5,786 |  |  | (1,057) |  |  | 21,237 |  |  | (1,057) |
Total other expense |  | (8,846) |  |  | (6,905) |  |  | (3,745) |  |  | (12,548) |
Net income (loss) |  | 16,593 |  |  | (20,441) |  |  | 61,432 |  |  | 10,866 |
Less: net income (loss) attributable to noncontrolling interests |  | 7,951 |  |  | (10,348) |  |  | 29,921 |  |  | 5,653 |
Net income (loss) attributable to BRP Group, Inc. |  | $ | 8,642 |  |  | $ | (10,093) |  |  | $ | 31,511 |  |  | $ | 5,213 |
Comprehensive income (loss) |  | $ | 16,593 |  |  | $ | (20,441) |  |  | $ | 61,432 |  |  | $ | 10,866 |
Comprehensive income (loss) attributable to noncontrolling interests |  | 7,951 |  |  | (10,348) |  |  | 29,921 |  |  | 5,653 |
Comprehensive income (loss) attributable to BRP Group, Inc. |  | 8,642 |  |  | (10,093) |  |  | 31,511 |  |  | 5,213 |
Basic earnings (loss) per share |  | $ | 0.15 |  |  | $ | (0.23) |  |  | $ | 0.56 |  |  | $ | 0.12 |
Diluted earnings (loss) per share |  | $ | 0.14 |  |  | $ | (0.23) |  |  | $ | 0.53 |  |  | $ | 0.11 |
Weighted-average shares of Class A common stock outstanding - basic |  | 56,270,491 |  | 44,671,308 |  | 55,996,668 |  | 44,464,312
Weighted-average shares of Class A common stock outstanding - diluted |  | 59,858,816 |  | 44,671,308 |  | 59,354,168 |  | 46,160,474

See accompanying Notes to Condensed Consolidated Financial Statements. 7

BRP GROUP, INC.
Condensed Consolidated Statements of Stockholders’ Equity and Mezzanine Equity
(Unaudited)

For the Three Months Ended June 30, 2022
| Stockholders’ Equity |  |  | Mezzanine Equity
| Class A Common Stock |  | Class B Common Stock |  | Additional Paid-in Capital |  | Accumulated Deficit |  | Stockholder Notes Receivable |  | Non-controlling Interest |  | Total |  |  | Redeemable Non-controlling Interest
(in thousands, except share data) | Shares |  | Amount |  | Shares |  | Amount |  |  |
Balance at March 31, 2022 | 58,790,758 |  | $ | 588 |  |  | 56,268,051 |  | $ | 6 |  |  | $ | 671,143 |  |  | $ | (32,123) |  |  | $ | (175) |  |  | $ | 599,308 |  |  | $ | 1,238,747 |  |  |  | $ | 288 |
Net income | — |  |  | — |  |  | — |  |  | — |  |  | — |  |  | 8,642 |  |  | — |  |  | 7,889 |  |  | 16,531 |  |  |  | 62 |
Equity issued in business combinations | 97,156 |  | 1 |  |  | — |  |  | — |  |  | (4,265) |  |  | — |  |  | — |  |  | 6,134 |  |  | 1,870 |  |  |  | — |
Share-based compensation, net of forfeitures | 430,741 |  | 4 |  |  | — |  |  | — |  |  | 7,109 |  |  | — |  |  | — |  |  | (449) |  |  | 6,664 |  |  |  | — |
Redemption and cancellation of Class B common stock | 804,187 |  |  | 8 |  |  | (825,616) |  |  | — |  |  | 9,344 |  |  | — |  |  | — |  |  | (9,352) |  |  | — |  |  |  | — |
Tax distributions to BRP LLC members | — |  |  | — |  |  | — |  |  | — |  |  | — |  |  | — |  |  | — |  |  | (4,321) |  |  | (4,321) |  |  |  | — |
Repayment of stockholder notes receivable | — |  |  | — |  |  | — |  |  | — |  |  | — |  |  | — |  |  | 44 |  |  | — |  |  | 44 |  |  |  | — |
Balance at June 30, 2022 | 60,122,842 |  | $ | 601 |  |  | 55,442,435 |  | $ | 6 |  |  | $ | 683,331 |  |  | $ | (23,481) |  |  | $ | (131) |  |  | $ | 599,209 |  |  | $ | 1,259,535 |  |  |  | $ | 350 |

For the Six Months Ended June 30, 2022
| Stockholders’ Equity |  |  | Mezzanine Equity
| Class A Common Stock |  | Class B Common Stock |  | Additional Paid-in Capital |  | Accumulated Deficit |  | Stockholder Notes Receivable |  | Non-controlling Interest |  | Total |  |  | Redeemable Non-controlling Interest
(in thousands, except share data) | Shares |  | Amount |  | Shares |  | Amount |  |  |
Balance at December 31, 2021 | 58,602,859 |  | $ | 586 |  |  | 56,338,051 |  | $ | 6 |  |  | $ | 663,002 |  |  | $ | (54,992) |  |  | $ | (219) |  |  | $ | 578,904 |  |  | $ | 1,187,287 |  |  |  | $ | 269 |
Net income | — |  |  | — |  |  | — |  |  | — |  |  | — |  |  | 31,511 |  |  | — |  |  | 29,840 |  |  | 61,351 |  |  |  | 81 |
Equity issued in business combinations | 97,156 |  | 1 |  |  | — |  |  | — |  |  | (4,265) |  |  | — |  |  | — |  |  | 6,134 |  |  | 1,870 |  |  |  | — |
Share-based compensation, net of forfeitures | 548,640 |  | 5 |  |  | — |  |  | — |  |  | 14,617 |  |  | — |  |  | — |  |  | (1,362) |  |  | 13,260 |  |  |  | — |
Redemption and cancellation of Class B common stock | 874,187 |  |  | 9 |  |  | (895,616) |  |  | — |  |  | 9,977 |  |  | — |  |  | — |  |  | (9,986) |  |  | — |  |  |  | — |
Tax distributions to BRP LLC members | — |  |  | — |  |  | — |  |  | — |  |  | — |  |  | — |  |  | — |  |  | (4,321) |  |  | (4,321) |  |  |  | — |
Repayment of stockholder notes receivable | — |  |  | — |  |  | — |  |  | — |  |  | — |  |  | — |  |  | 88 |  |  | — |  |  | 88 |  |  |  | — |
Balance at June 30, 2022 | 60,122,842 |  | $ | 601 |  |  | 55,442,435 |  | $ | 6 |  |  | $ | 683,331 |  |  | $ | (23,481) |  |  | $ | (131) |  |  | $ | 599,209 |  |  | $ | 1,259,535 |  |  |  | $ | 350 |

See accompanying Notes to Condensed Consolidated Financial Statements. 8

BRP GROUP, INC.
Condensed Consolidated Statements of Stockholders’ Equity and Mezzanine Equity (Continued)
(Unaudited)

For the Three Months Ended June 30, 2021
| Stockholders’ Equity |  |  | Mezzanine Equity
| Class A Common Stock |  | Class B Common Stock |  | Additional Paid-in Capital |  | Accumulated Deficit |  | Stockholder Notes Receivable |  | Non-controlling Interest |  | Total |  |  | Redeemable Non-controlling Interest
(in thousands, except share data) | Shares |  | Amount |  | Shares |  | Amount |  |  |
Balance at March 31, 2021 | 45,925,711 |  | $ | 460 |  |  | 49,715,644 |  | $ | 5 |  |  | $ | 398,885 |  |  | $ | (9,040) |  |  | $ | (349) |  |  | $ | 416,253 |  |  | $ | 806,214 |  |  |  | $ | 125 |
Net income (loss) | — |  |  | — |  |  | — |  |  | — |  |  | — |  |  | (10,093) |  |  | — |  |  | (10,396) |  |  | (20,489) |  |  |  | 48 |
Equity issued in business combinations | 62,152 |  |  | — |  |  | — |  | — |  |  | (1,773) |  |  | — |  |  | — |  |  | 3,028 |  |  | 1,255 |  |  |  | — |
Share-based compensation, net of forfeitures | 455,946 |  |  | 5 |  |  | — |  |  | — |  |  | 5,734 |  |  | — |  |  | — |  |  | (232) |  |  | 5,507 |  |  |  | — |
Redemption of Class B common stock | 139,773 |  |  | 1 |  |  | (139,773) |  |  | — |  |  | 1,179 |  |  | — |  |  | — |  |  | (1,180) |  |  | — |  |  |  | — |
Repayment of stockholder notes receivable | — |  |  | — |  |  | — |  |  | — |  |  | — |  |  | — |  |  | 43 |  |  | — |  |  | 43 |  |  |  | — |
Balance at June 30, 2021 | 46,583,582 |  | $ | 466 |  |  | 49,575,871 |  | $ | 5 |  |  | $ | 404,025 |  |  | $ | (19,133) |  |  | $ | (306) |  |  | $ | 407,473 |  |  | $ | 792,530 |  |  |  | $ | 173 |

For the Six Months Ended June 30, 2021
| Stockholders’ Equity |  |  | Mezzanine Equity
| Class A Common Stock |  | Class B Common Stock |  | Additional Paid-in Capital |  | Accumulated Deficit |  | Stockholder Notes Receivable |  | Non-controlling Interest |  | Total |  |  | Redeemable Non-controlling Interest
(in thousands, except share data) | Shares |  | Amount |  | Shares |  | Amount |  |  |
Balance at December 31, 2020 | 44,953,166 |  | $ | 450 |  |  | 49,828,383 |  | $ | 5 |  |  | $ | 392,139 |  |  | $ | (24,346) |  |  | $ | (465) |  |  | $ | 402,087 |  |  | $ | 769,870 |  |  |  | $ | 98 |
Net income | — |  |  | — |  |  | — |  |  | — |  |  | — |  |  | 5,213 |  |  | — |  |  | 5,578 |  |  | 10,791 |  |  |  | 75 |
Equity issued in business combinations | 216,284 |  |  | 2 |  |  | — |  | — |  |  | 1,859 |  |  | — |  |  | — |  |  | 1,853 |  |  | 3,714 |  |  |  | — |
Share-based compensation, net of forfeitures | 1,161,620 |  |  | 12 |  |  | — |  |  | — |  |  | 7,979 |  |  | — |  |  | — |  |  | 5 |  |  | 7,996 |  |  |  | — |
Redemption of Class B common stock | 252,512 |  |  | 2 |  |  | (252,512) |  |  | — |  |  | 2,048 |  |  | — |  |  | — |  |  | (2,050) |  |  | — |  |  |  | — |
Repayment of stockholder notes receivable | — |  |  | — |  |  | — |  |  | — |  |  | — |  |  | — |  |  | 159 |  |  | — |  |  | 159 |  |  |  | — |
Balance at June 30, 2021 | 46,583,582 |  | $ | 466 |  |  | 49,575,871 |  | $ | 5 |  |  | $ | 404,025 |  |  | $ | (19,133) |  |  | $ | (306) |  |  | $ | 407,473 |  |  | $ | 792,530 |  |  |  | $ | 173 |

See accompanying Notes to Condensed Consolidated Financial Statements. 9

BRP GROUP, INC.
Condensed Consolidated Statements of Cash Flows
(Unaudited)

|  | For the Six Months Ended June 30,
(in thousands) |  | 2022 |  | 2021
Cash flows from operating activities: |  |  |  |
Net income |  | $ | 61,432 |  |  | $ | 10,866 |
Adjustments to reconcile net income to net cash provided by (used in) operating activities: |  |  |  |
Depreciation and amortization |  | 38,825 |  |  | 22,446 |
Change in fair value of contingent consideration |  | (32,504) |  |  | 11,822 |
Share-based compensation expense |  | 17,677 |  |  | 8,087 |
Amortization of deferred financing costs |  | 2,474 |  |  | 1,443 |
Change in fair value of interest rate caps |  | (21,269) |  |  | 825 |
Other fair value adjustments |  | — |  |  | 94 |
Payment of contingent earnout consideration in excess of purchase price accrual |  | (47,803) |  |  | (602) |
Changes in operating assets and liabilities, net of effect of acquisitions: |  |  |  |
Premiums, commissions and fees receivable, net |  | (78,365) |  |  | (52,357) |
Prepaid expenses and other current assets |  | (10,061) |  |  | (2,085) |
Due to/from related parties |  | (47) |  |  | 84 |
Right-of-use assets |  | (4,116) |  |  | (57,816) |
Accounts payable, accrued expenses and other current liabilities |  | 63,763 |  |  | 47,436 |
Operating lease liabilities |  | 5,353 |  |  | 59,176 |
Net cash provided by (used in) operating activities |  | (4,641) |  |  | 49,419 |
Cash flows from investing activities: |  |  |  |
Cash consideration paid for business combinations, net of cash received |  | (377,299) |  |  | (24,276) |
Cash consideration paid for asset acquisitions, net of cash received |  | (3,356) |  |  | (1,575) |
Capital expenditures |  | (8,565) |  |  | (1,756) |
Investment in business venture |  | (675) |  |  | — |
Net cash used in investing activities |  | (389,895) |  |  | (27,607) |
Cash flows from financing activities: |  |  |  |
Payment of contingent earnout consideration up to amount of purchase price accrual |  | (43,184) |  |  | (828) |
Proceeds from revolving line of credit |  | 495,000 |  |  | 20,000 |
Payments on revolving line of credit |  | (5,000) |  |  | — |
Proceeds from long-term debt |  | — |  |  | 97,914 |
Payments on long-term debt |  | (4,254) |  |  | (1,000) |
Payments of debt issuance costs |  | (1,565) |  |  | (634) |
Proceeds from the sale of interest rate caps |  | 19,038 |  |  | — |
Tax distributions to BRP LLC members |  | (9,393) |  |  | — |
Purchase of interest rate caps |  | — |  |  | (3,461) |
Proceeds from repayment of stockholder notes receivable |  | 88 |  |  | 159 |
Net cash provided by financing activities |  | 450,730 |  |  | 112,150 |
Net increase in cash and cash equivalents and restricted cash |  | 56,194 |  |  | 133,962 |
Cash and cash equivalents and restricted cash at beginning of period |  | 227,737 |  |  | 142,022 |
Cash and cash equivalents and restricted cash at end of period |  | $ | 283,931 |  |  | $ | 275,984 |

See accompanying Notes to Condensed Consolidated Financial Statements. 10

BRP GROUP, INC.
Condensed Consolidated Statements of Cash Flows (Continued)
(Unaudited)

|  | For the Six Months Ended June 30,
(in thousands) |  | 2022 |  | 2021
Supplemental schedule of cash flow information: |  |  |  |
Cash paid during the period for interest |  | $ | 22,001 |  |  | $ | 11,024 |
Cash paid during the period for taxes |  | 864 |  |  | — |
Disclosure of non-cash investing and financing activities: |  |  |  |
Contingent earnout liabilities recognized in business combinations |  | $ | 13,398 |  |  | $ | 7,764 |
Right-of-use assets obtained in exchange for operating lease liabilities |  | 8,010 |  |  | 5,766 |
Right-of-use assets increased through lease modifications and reassessments |  | 4,440 |  |  | 1,054 |
Increase in goodwill resulting from measurement period adjustments for prior year business combinations |  | 3,499 |  |  | — |
Equity issued in business combinations |  | 1,870 |  |  | 3,714 |
Capital expenditures incurred but not yet paid |  | 923 |  |  | 33 |
Noncash debt issuance costs incurred |  | — |  |  | 3,823 |

See accompanying Notes to Condensed Consolidated Financial Statements. 11

BRP GROUP, INC.
Notes to Condensed Consolidated Financial Statements
(Unaudited)
1. Business and Basis of Presentation
BRP Group, Inc. (“BRP Group” or the “Company”) was incorporated in the state of Delaware on July 1, 2019. BRP Group is a diversified insurance agency and services organization that markets and sells insurance products and services to its customers throughout the U.S. A significant portion of the Company’s business is concentrated in the Southeastern U.S. with several other regional concentrations. BRP Group and its subsidiaries operate through four Operating Groups, including Middle Market, Specialty, MainStreet, and Medicare, which are discussed in more detail in Note 15.
Principles of Consolidation
The consolidated financial statements include the accounts of BRP Group and its wholly-owned subsidiaries. All intercompany transactions and balances have been eliminated in consolidation.
As the sole manager of Baldwin Risk Partners, LLC (“BRP”), BRP Group operates and controls all the business and affairs of BRP, and has the sole voting interest in, and controls the management of, BRP. Accordingly, BRP Group consolidates BRP in its consolidated financial statements, resulting in a noncontrolling interest related to the membership interests of BRP (the “LLC Units”) held by BRP’s LLC members in its consolidated financial statements.
The Company has prepared these condensed consolidated financial statements in accordance with Accounting Standards Codification (“ASC”) Topic 810, Consolidation (“Topic 810”). Topic 810 requires that if an enterprise is the primary beneficiary of a variable interest entity, the assets, liabilities, and results of operations of the variable interest entity should be included in the consolidated financial statements of the enterprise. The Company has recognized certain entities as variable interest entities of which the Company is the primary beneficiary and has included the accounts of these entities in the consolidated financial statements. Refer to Note 3 for additional information regarding the Company’s variable interest entities.
Topic 810 also requires that the equity of a noncontrolling interest shall be reported on the condensed consolidated balance sheets within total equity of the Company. Certain redeemable noncontrolling interests are reported on the condensed consolidated balance sheets as mezzanine equity. Topic 810 also requires revenues, expenses, gains, losses, net income or loss, and other comprehensive income or loss to be reported in the consolidated financial statements at consolidated amounts, which include amounts attributable to the owners of the parent and the noncontrolling interests.
Unaudited Interim Financial Reporting
The accompanying unaudited interim condensed consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America (“GAAP”) and applicable rules and regulations of the Securities and Exchange Commission (“SEC”) regarding interim financial reporting. Accordingly, they do not include all the information and related notes required by GAAP for complete consolidated financial statements. In the opinion of management, all adjustments, consisting of recurring accruals, considered necessary for fair statement have been included. The accompanying balance sheet for the year ended December 31, 2021 was derived from audited financial statements, but does not include all disclosures required by GAAP. Accordingly, these unaudited interim condensed consolidated financial statements should be read in conjunction with the Company’s audited consolidated financial statements and the notes thereto for the year ended December 31, 2021 included in the Company’s Annual Report on Form 10-K filed with the SEC on March 1, 2022.
Use of Estimates
The preparation of consolidated financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, disclosures of contingent assets and liabilities at the date of the consolidated financial statements and the reported amounts of revenue and expenses during the reporting period. Actual results could differ from these estimates. Significant estimates underlying the accompanying consolidated financial statements include the application of guidance for revenue recognition, including determination of allowances for estimated policy cancellations; the determination of fair value in relation to business combinations, purchase price allocation and valuation of intangible assets and contingent consideration; impairment of long-lived assets including goodwill; valuation of the Tax Receivable Agreement liability and income taxes; and share-based compensation.
12

Changes in Presentation
Certain prior year amounts have been reclassified to conform to current year presentation. The Company reclassified its wealth business revenue from other income to consulting and service fee revenue in the disaggregated revenue table in Note 4.
The Company identified an error in the March 31, 2022 financial statements related to commissions expense. We have corrected this error in the second quarter of 2022 as an out-of-period adjustment, which resulted in $5.5 million of commissions expense in the condensed consolidated statement of comprehensive income (loss) for the three months ended June 30, 2022. There was no impact to commissions expense in the condensed consolidated statement of comprehensive income (loss) for the six months ended June 30, 2022.
Recent Accounting Pronouncements
In October 2021, the FASB issued Accounting Standards Update (“ASU”) No. 2021-08, Business Combinations (Topic 805)—Accounting for Contract Assets and Contract Liabilities from Contracts with Customers (“ASU 2021-08”) to improve the accounting for acquired revenue contracts with customers in business combination by addressing diversity in practice and inconsistency related to (i) the recognition of an acquired contract liability and (ii) payment terms and their effect on subsequent revenue recognized by the acquirer. ASU 2021-08 requires that, at acquisition date, an entity recognize and measure contract assets and contract liabilities acquired in a business combination in accordance with ASC Topic 606, Revenue from Contracts with Customers (“Topic 606”) as if it had originated the contracts, while also taking into account how the acquiree applied Topic 606. This guidance is effective for fiscal years, and interim periods within those fiscal years, beginning after December 15, 2022, with early adoption permitted. The Company is currently evaluating the full effect that the adoption of this standard will have on its consolidated financial statements.
Adoption of the Lease Accounting Standard Under Topic 842
On December 31, 2021, the Company adopted ASU No. 2016-02, Leases (“Topic 842”) in connection with the loss of its emerging growth company status. Topic 842 was adopted effective January 1, 2021 (the “adoption date”) on a modified retrospective basis, under which the Company applied the new guidance to leases existing at, or entered into after, the adoption date. The Company revised its previously reported consolidated financial statements effective January 1, 2021 in its Form 10-K for the year ended December 31, 2021 without filing amendments to its previously filed quarterly reports on Form 10-Q for the same year. Accordingly, our prior period condensed consolidated financial statements and information, as presented herein, have been revised to conform to the standard.
The following table summarizes the effects of adopting ASC 842 on our condensed consolidated statements of comprehensive income (loss) for the three and six months ended June 30, 2021:

| For the Three Months Ended June 30, 2021 |  | For the Six Months Ended June 30, 2021
(in thousands, except per share data) | As Previously Reported |  | Effect of Adoption of Topic 842 |  | As Adjusted |  | As Previously Reported |  | Effect of Adoption of Topic 842 |  | As Adjusted
Operating expenses: |  |  |  |  |  |  |  |  |  |  |
Other operating expenses | $ | 19,200 |  |  | $ | 337 |  |  | $ | 19,537 |  |  | $ | 36,768 |  |  | $ | (356) |  |  | $ | 36,412 |
Total operating expenses | 132,905 |  |  | 337 |  |  | 133,242 |  |  | 249,476 |  |  | (356) |  |  | 249,120 |
Operating income (loss) | (13,199) |  |  | (337) |  |  | (13,536) |  |  | 23,058 |  |  | 356 |  |  | 23,414 |
Net income (loss) | (20,104) |  |  | (337) |  |  | (20,441) |  |  | 10,510 |  |  | 356 |  |  | 10,866 |
Net income (loss) attributable to BRP Group, Inc. | (9,756) |  |  | (337) |  |  | (10,093) |  |  | 4,857 |  |  | 356 |  |  | 5,213 |
Basic earnings (loss) per share | $ | (0.22) |  |  | $ | (0.01) |  |  | $ | (0.23) |  |  | $ | 0.11 |  |  | $ | 0.01 |  |  | $ | 0.12 |
Diluted earnings (loss) per share | $ | (0.22) |  |  | $ | (0.01) |  |  | $ | (0.23) |  |  | $ | 0.11 |  |  | $ | — |  |  | $ | 0.11 |

13

The following table summarizes the effects of adopting ASC 842 on our condensed consolidated statement of cash flows for the six months ended June 30, 2021:

|  | For the Six Months Ended June 30, 2021
(in thousands) |  | As Previously Reported |  | Effect of Adoption of Topic 842 |  | As Adjusted
Cash flows from operating activities: |  |  |  |  |  |
Net income |  | $ | 10,510 |  |  | $ | 356 |  |  | $ | 10,866 |
Changes in operating assets and liabilities, net of effect of acquisitions: |  |  |  |  |  |
Prepaid expenses and other current assets |  | (2,254) |  |  | 169 |  |  | (2,085) |
Right-of-use assets |  | — |  |  | (57,816) |  |  | (57,816) |
Accounts payable, accrued expenses and other current liabilities |  | 49,321 |  |  | (1,885) |  |  | 47,436 |
Operating lease liabilities |  | — |  |  | 59,176 |  |  | 59,176 |

2. Business Combinations
The Company completed two business combinations for an aggregate purchase price of $396.4 million during the six months ended June 30, 2022. In accordance with ASC Topic 805, Business Combinations (“Topic 805”), total consideration was first allocated to the fair value of assets acquired, including liabilities assumed, with the excess being recorded as goodwill. For financial statement purposes, goodwill is not amortized but rather is evaluated for impairment at least annually or more frequently if an event or change in circumstances occurs that indicates goodwill may be impaired. For tax purposes, goodwill is deductible and will be amortized over a period of 15 years.
The Company completed the following business combinations during the six months ended June 30, 2022:
•Westwood Insurance Agency (“Westwood”), a MainStreet Partner effective April 29, 2022, enhances the Company’s expertise and capabilities in embedded, tech-enabled homeowners’ insurance solutions.
•Venture Captive Management, LLC (“VCM”), a Specialty Partner effective June 3, 2022, expands the Company’s capabilities into captive management and alternative risk funding solutions for clients.
The recorded purchase price for business combinations includes an estimation of the fair value of contingent consideration obligations associated with potential earnout provisions, which are based on recurring revenue or the insured value of sourced homeowners’ insurance of Westwood. The contingent earnout consideration amounts identified in the tables below are measured at fair value within Level 3 of the fair value hierarchy as discussed further in Note 13. Any subsequent changes in the fair value of contingent earnout liabilities will be recorded in the condensed consolidated statements of comprehensive income (loss) when incurred.
The recorded purchase price for certain business combinations also includes an estimation of the fair value of equity interests, which is calculated based on the value of the Company’s Class A common stock on the closing date taking into account a discount for lack of marketability.
The operating results of these business combinations have been included in the condensed consolidated statements of comprehensive income (loss) since their respective acquisition dates. The Company recognized total revenues and net income from these business combinations of $18.2 million and $7.0 million, respectively, for each of the three and six months ended June 30, 2022.
Acquisition-related costs incurred in connection with these business combinations are recorded in other operating expenses in the condensed consolidated statements of comprehensive income (loss). The Company incurred acquisition-related costs from these business combinations of $1.9 million for the six months ended June 30, 2022.
Due to the complexity of valuing the consideration paid and the purchase price allocation and the timing of these activities, certain amounts included in the consolidated financial statements may be provisional and subject to additional adjustments within the measurement period as permitted by Topic 805. Specifically, the Company's valuations of premiums, commissions and fees receivable in accordance with Topic 606 are estimates subject to change based on relevant factors over the policy period. The valuations of intangible assets are also estimates based on assumptions of factors such as discount rates and growth rates. Accordingly, these assets are subject to measurement period adjustments as determined after the passage of time. Any measurement period adjustments related to prior period business combinations are reflected as current period adjustments in accordance with Topic 805.
14

The table below provides a summary of the total consideration and the estimated purchase price allocations made for each of the business acquisitions that became effective during the six months ended June 30, 2022.

(in thousands) | Westwood |  | VCM |  | Totals
Cash consideration paid | $ | 373,554 |  |  | $ | 5,850 |  |  | $ | 379,404 |
Fair value of contingent earnout consideration | 12,724 |  |  | 674 |  |  | 13,398 |
Fair value of equity interest | — |  |  | 1,870 |  |  | 1,870 |
Deferred payment | — |  |  | 1,716 |  |  | 1,716 |
Total consideration | $ | 386,278 |  |  | $ | 10,110 |  |  | $ | 396,388 |
Cash | $ | 658 |  |  | $ | 1,397 |  |  | $ | 2,055 |
Restricted cash | 50 |  |  | — |  |  | 50 |
Premiums, commissions and fees receivable | 4,225 |  |  | 157 |  |  | 4,382 |
Other assets | 392 |  |  | 566 |  |  | 958 |
Intangible assets | 209,200 |  |  | 2,984 |  |  | 212,184 |
Goodwill | 176,176 |  |  | 6,865 |  |  | 183,041 |
Total assets acquired | 390,701 |  |  | 11,969 |  |  | 402,670 |
Premiums payable to insurance companies | (218) |  |  | — |  |  | (218) |
Producer commissions payable | (2,488) |  |  | — |  |  | (2,488) |
Accrued expenses and other current liabilities | (1,717) |  |  | (1,859) |  |  | (3,576) |
Total liabilities acquired | (4,423) |  |  | (1,859) |  |  | (6,282) |
Net assets acquired | $ | 386,278 |  |  | $ | 10,110 |  |  | $ | 396,388 |
Maximum potential contingent earnout consideration | $ | 15,000 |  |  | $ | 1,250 |  |  | $ | 16,250 |

The factors contributing to the recognition of goodwill are based on expanding business presence into new service markets, strategic benefits expected to be realized from acquiring the Partners’ assembled workforce and technology, in addition to other synergies gained from integrating the Partners’ operations into our consolidated structure.
The intangible assets acquired in connection with business combinations during the six months ended June 30, 2022 have the following values and estimated weighted-average lives:

(in thousands, except weighted-average lives) | Amount |  | Weighted-Average Life
Purchased customer accounts | $ | 18,550 |  |  | 20.0 years
Distributor relationships | 159,800 |  |  | 20.0 years
Software | 29,500 |  |  | 5.0 years
Trade names | 4,334 |  |  | 5.0 years

Future annual estimated amortization expense over the next five years for intangible assets acquired in connection with business combinations during the six months ended June 30, 2022 is as follows:

(in thousands) |  | Amount
For the remainder of 2022 |  | $ | 5,049 |
2023 |  | 11,076 |
2024 |  | 12,340 |
2025 |  | 13,562 |
2026 |  | 14,437 |

15

The following pro forma consolidated results of operations are provided for illustrative purposes only and have been presented as if the acquisitions of Westwood and VCM occurred on January 1, 2021. This pro forma information should not be relied upon as being indicative of the historical results that would have been obtained if the acquisitions had occurred on that date, nor of the results that may be obtained in the future.

|  | For the Three Months Ended June 30, |  | For the Six Months Ended June 30,
(in thousands, except per share data) |  | 2022 |  | 2021 |  | 2022 |  | 2021
Pro forma results: |  |  |  |  |  |  |  |
Revenues |  | $ | 239,912 |  |  | $ | 140,906 |  |  | $ | 503,058 |  |  | $ | 313,572 |
Net income (loss) |  | 15,753 |  |  | (21,759) |  |  | 60,370 |  |  | 8,970 |
Net income (loss) attributable to BRP Group, Inc. |  | 8,207 |  |  | (10,731) |  |  | 30,965 |  |  | 4,300 |
Basic earnings (loss) per share |  | $ | 0.15 |  |  | $ | (0.24) |  |  | $ | 0.55 |  |  | $ | 0.10 |
Diluted earnings (loss) per share |  | $ | 0.14 |  |  | $ | (0.24) |  |  | $ | 0.52 |  |  | $ | 0.09 |
Weighted-average shares of Class A common stock outstanding - basic |  | 56,339 |  |  | 44,768 |  |  | 56,079 |  |  | 44,561 |
Weighted-average shares of Class A common stock outstanding - diluted |  | 60,022 |  |  | 44,768 |  |  | 59,628 |  |  | 46,543 |

3. Variable Interest Entities
Topic 810 requires a reporting entity to consolidate a variable interest entity (“VIE”) when the reporting entity has a variable interest or combination of variable interests that provide the entity with a controlling financial interest in the VIE. The Company continually assesses whether it has a controlling financial interest in each of its VIEs to determine if it is the primary beneficiary of the VIE and should, therefore, consolidate each of the VIEs. A reporting entity is considered to have a controlling financial interest in a VIE if it has (i) the power to direct the activities of a VIE that most significantly impact the VIE’s economic performance, and (ii) the obligation to absorb the losses of, or the right to receive benefits from, the VIE that could potentially be significant to the VIE.
The Company determined that it is the primary beneficiary of its VIEs, which, at June 30, 2022 and December 31, 2021, include Laureate Insurance Partners, LLC, BKS Smith, LLC, BKS MS, LLC and BKS Partners Galati Marine Solutions, LLC. The Company has consolidated its VIEs into the condensed consolidated financial statements.
Total revenues and expenses of the Company’s consolidated VIEs included in the condensed consolidated statements of comprehensive income (loss) were $0.4 million and $0.3 million, respectively, for the three months ended June 30, 2022 and $0.3 million and $0.2 million, respectively, for the three months ended June 30, 2021. Total revenues and expenses of the Company’s consolidated VIEs included in the condensed consolidated statements of comprehensive income (loss) were $0.8 million and $0.5 million, respectively, for the six months ended June 30, 2022 and $0.5 million and $0.3 million, respectively, for the six months ended June 30, 2021.
The assets of the consolidated VIEs can only be used to settle the obligations of the consolidated VIEs and the creditors of the liabilities of the consolidated VIEs do not have recourse to the Company.
16

4. Revenue
The following table provides disaggregated commissions and fees revenue by major source:

|  | For the Three Months Ended June 30, |  | For the Six Months Ended June 30,
(in thousands) |  | 2022 |  | 2021 |  | 2022 |  | 2021
Direct bill revenue(1) |  | $ | 93,534 |  |  | $ | 50,358 |  |  | $ | 225,194 |  |  | $ | 144,863 |
Agency bill revenue(2) |  | 89,015 |  |  | 47,293 |  |  | 162,192 |  |  | 82,633 |
Profit-sharing revenue(3) |  | 19,366 |  |  | 8,175 |  |  | 34,378 |  |  | 18,467 |
Consulting and service fee revenue(4) |  | 12,188 |  |  | 7,570 |  |  | 26,525 |  |  | 14,577 |
Policy fee and installment fee revenue(5) |  | 13,419 |  |  | 4,792 |  |  | 19,127 |  |  | 9,268 |
Other income(6) |  | 4,938 |  |  | 1,518 |  |  | 7,892 |  |  | 2,726 |
Total commissions and fees |  | $ | 232,460 |  |  | $ | 119,706 |  |  | $ | 475,308 |  |  | $ | 272,534 |

__________
(1) Direct bill revenue represents commission revenue earned by facilitating the arrangement between individuals or businesses and Insurance Company Partners by providing insurance placement services to Clients, primarily for private risk management, commercial risk management, employee benefits and Medicare insurance types.
(2) Agency bill revenue primarily represents commission revenue earned by facilitating the arrangement between individuals or businesses and Insurance Company Partners by providing insurance placement services to Clients. The Company acts as an agent on behalf of the Client.
(3) Profit-sharing revenue represents bonus-type revenue that is earned by the Company as a sales incentive provided by certain Insurance Company Partners.
(4) Service fee revenue is earned by receiving negotiated fees in lieu of a commission and consulting revenue is earned by providing specialty insurance consulting.
(5) Policy fee revenue represents revenue earned for acting in the capacity of an MGA on behalf of the Insurance Company Partner and fulfilling certain services including delivery of policy documents, processing payments and other administrative functions. Installment fee revenue represents revenue earned by the Company for providing payment processing services on behalf of the Insurance Company Partner related to policy premiums paid on an installment basis.
(6) Other income consists of Medicare marketing income that is based on agreed-upon cost reimbursement for fulfilling specific targeted marketing campaigns in addition to other ancillary income and premium financing income generated across all Operating Groups.
The application of Topic 606 requires the use of management judgment. The following are the areas of most significant judgment as it relates to Topic 606:
•The Company considers the policyholders as representative of its customers in the majority of contractual relationships, with the exception of contracts in its Medicare operating segment, where the Insurance Company Partner is considered its customer.
•Contracts in the Medicare operating segment are multi-year arrangements in which the Company is entitled to renewal commissions. However, the Company has applied a constraint to renewal commission that limits revenue recognized on new policies to the policy year in effect, and revenue recognized on renewed policies to the receipt of periodic cash, when a risk of significant reversals exists based on: (i) insufficient history; and (ii) the influence of external factors outside of the Company’s control, including policyholder discretion over plans and Insurance Company Partner relationship, political influence, and a contractual provision, which limits the Company’s right to receive renewal commissions to ongoing compliance and regulatory approval of the relevant Insurance Company Partner and compliance with the Centers for Medicare and Medicaid Services.
•The Company recognizes separately contracted commissions revenue at the effective date of insurance placement and considers any ongoing interaction with the customer to be immaterial in the context of the contract.
•Variable consideration includes estimates of direct bill commissions, a reserve for policy cancellations and an estimate of profit-sharing revenue.
•Costs to obtain a contract are deferred and recognized over five years, which represents management’s estimate of the average period over which a Client maintains its initial coverage relationship with the original Insurance Company Partner.
•Due to the relatively short time period between the information gathering phase and binding insurance coverage, the Company has determined that costs to fulfill contracts are not significant. Therefore, costs to fulfill a contract are expensed as incurred.
17

5. Contract Assets and Liabilities
Contract assets arise when the Company recognizes revenue for amounts which have not yet been billed and contract liabilities relate to payments received in advance of performance under the contract before the transfer of a good or service to the customer. Contract assets are included in premiums, commissions and fees receivable, net and contract liabilities are included in accrued expenses and other current liabilities on the condensed consolidated balance sheets. The balances of contract assets and liabilities arising from contracts with customers are as follows:

(in thousands) |  | June 30, 2022 |  | December 31, 2021
Contract assets |  | $ | 186,477 |  |  | $ | 168,550 |
Contract liabilities |  | 25,191 |  |  | 18,178 |

During the six months ended June 30, 2022, the Company recognized revenue of $16.7 million related to the contract liabilities balance at December 31, 2021.
6. Deferred Commission Expense
The Company pays an incremental amount of compensation in the form of producer commissions on new business. In accordance with ASC Topic 340, Other Assets and Deferred Costs, these incremental costs are deferred and amortized over five years, which represents management’s estimate of the average benefit period for new business. Deferred commission expense represents employee commissions that are capitalized and not yet expensed and are included in other assets on the condensed consolidated balance sheets. The table below provides a rollforward of deferred commission expense for the periods presented:

|  | For the Three Months Ended June 30, |  | For the Six Months Ended June 30,
(in thousands) |  | 2022 |  | 2021 |  | 2022 |  | 2021
Balance at beginning of period |  | $ | 14,039 |  |  | $ | 5,164 |  |  | $ | 11,336 |  |  | $ | 4,751 |
Costs capitalized |  | 3,238 |  |  | 1,351 |  |  | 6,868 |  |  | 2,186 |
Amortization |  | (1,079) |  |  | (479) |  |  | (2,006) |  |  | (901) |
Balance at end of period |  | $ | 16,198 |  |  | $ | 6,036 |  |  | $ | 16,198 |  |  | $ | 6,036 |

7. Intangible Assets, Net and Goodwill
The Company recognizes certain separately identifiable intangible assets acquired in connection with business combinations and asset acquisitions. Intangible assets consist of the following:

|  | June 30, 2022 |  | December 31, 2021
(in thousands) |  | Gross Carrying Value |  | Accumulated Amortization |  | Net Carrying Value |  | Gross Carrying Value |  | Accumulated Amortization |  | Net Carrying Value
Purchased customer accounts |  | $ | 873,351 |  |  | $ | (80,436) |  |  | $ | 792,915 |  |  | $ | 851,445 |  |  | $ | (54,481) |  |  | $ | 796,964 |
Distributor relationships |  | 260,421 |  |  | (6,976) |  |  | 253,445 |  |  | 100,621 |  |  | (3,814) |  |  | 96,807 |
Software |  | 73,357 |  |  | (23,563) |  |  | 49,794 |  |  | 41,743 |  |  | (18,265) |  |  | 23,478 |
Trade names |  | 28,523 |  |  | (5,713) |  |  | 22,810 |  |  | 24,189 |  |  | (3,583) |  |  | 20,606 |
Carrier relationships |  | 7,859 |  |  | (1,435) |  |  | 6,424 |  |  | 7,859 |  |  | (1,247) |  |  | 6,612 |
Totals |  | $ | 1,243,511 |  |  | $ | (118,123) |  |  | $ | 1,125,388 |  |  | $ | 1,025,857 |  |  | $ | (81,390) |  |  | $ | 944,467 |

Amortization expense recorded for intangible assets was $19.2 million and $10.7 million for the three months ended June 30, 2022 and 2021, respectively, and $36.7 million and $21.3 million for the six months ended June 30, 2022 and 2021, respectively.
18

Refer to Note 2 for a summary of goodwill recorded in connection with business combinations during the six months ended June 30, 2022. The changes in carrying value of goodwill by Operating Group for the periods are as follows:

(in thousands) |  | Middle Market |  | Specialty |  | MainStreet |  | Medicare |  | Total
Balance at December 31, 2021 |  | $ | 901,127 |  |  | $ | 264,018 |  |  | $ | 38,892 |  |  | $ | 24,704 |  |  | $ | 1,228,741 |
Goodwill of acquired businesses |  | — |  |  | 6,865 |  |  | 176,176 |  |  | — |  |  | 183,041 |
Measurement period adjustments(1) |  | 2,983 |  |  | 516 |  |  | — |  |  | — |  |  | 3,499 |
Balance at June 30, 2022 |  | $ | 904,110 |  |  | $ | 271,399 |  |  | $ | 215,068 |  |  | $ | 24,704 |  |  | $ | 1,415,281 |

__________
(1) Measurement period adjustments relating to businesses acquired in the fourth quarter of 2021 increased premiums, commissions and fees receivable by $3.7 million, increased current liabilities by $7.0 million and increased consideration by $0.2 million.
8. Accrued Expenses and Other Current Liabilities
Accrued expenses and other current liabilities consist of the following:

(in thousands) |  | June 30, 2022 |  | December 31, 2021
Contract liabilities |  | $ | 25,191 |  |  | $ | 18,178 |
Accrued compensation and benefits |  | 24,549 |  |  | 22,460 |
Current portion of operating lease liabilities |  | 12,843 |  |  | 12,520 |
Deferred consideration payments |  | 12,656 |  |  | 12,355 |
Accrued expenses |  | 10,943 |  |  | 9,731 |
Current portion of long-term debt |  | 8,509 |  |  | 8,521 |
Advisor incentive liability |  | 4,784 |  |  | — |
Tax distribution payable |  | — |  |  | 5,072 |
Other |  | 4,855 |  |  | 3,386 |
Accrued expenses and other current liabilities |  | $ | 104,330 |  |  | $ | 92,223 |

BRP previously had advisor incentive agreements with several of its Risk Advisors to incentivize them to stay with the Company and grow their Book of Business. The incentive rights had a deposit buy-in requirement payable in the form of payroll withholding or other cash payments for which the Company recorded an advisor incentive liability. The incentive rights could be converted to LLC Units after the achievement of certain milestones, subject to approval at the discretion of management. The Company’s obligation related to advisor incentive liabilities of all but one Risk Advisor was settled in connection with our reorganization during 2019. One Risk Advisor chose not to convert his incentive rights into common stock of BRP Group. As a result, the remaining advisor incentive liability has been reported at fair value of the expected buyout amount each reporting period as a component of other liabilities in the accompanying balance sheets.
During the second quarter of 2022, the Company entered into an agreement with this Risk Advisor to settle the advisor incentive liability for $4.8 million and the obligation was subsequently satisfied in the third quarter of 2022. The advisor incentive liability was reclassified from other liabilities to accrued expenses and other current liabilities at June 30, 2022 as a result of the settlement agreement.
9. Long-Term Debt
As of December 31, 2021, the Company’s JPM Credit Agreement provided for senior secured credit facilities in an aggregate principal amount of $1.325 billion, which consisted of (i) a term loan facility in the principal amount of $850.0 million maturing in 2027 (the “Term Loan B”) and (ii) a revolving credit facility with commitments in an aggregate principal amount of $475.0 million maturing in 2025 (the “Revolving Facility”).
On March 28, 2022, the Company entered into Amendment No. 5 to the JPM Credit Agreement, under which (i) the aggregate principal amount of the Revolving Facility was increased from $475.0 million to $600.0 million, (ii) the interest rate on the Revolving Facility changed to the SOFR, plus a credit spread adjustment of 10 bps plus an amount between 200 bps and 300 bps based on the total net leverage ratio, (iii) the total net leverage ratio covenant increased to 7.0x consolidated earnings before interest, taxes, depreciation and amortization (“EBITDA”) and (iv) the maturity of the Revolving Facility was extended to April 1, 2027. The other terms of the Revolving Facility and the terms of the Term Loan B remained unchanged. The JPM Credit Agreement provides for a benchmark replacement to SOFR such that there are no material contract modifications resulting from a transition from LIBOR.
19

The Term Loan B bears interest at LIBOR plus 350 bps, subject to a LIBOR floor of 50 bps. At June 30, 2022, the outstanding borrowings on the Term Loan B were $842.4 million and had an applicable interest rate of 4.69%. The outstanding borrowings on the Revolving Facility of $525.0 million had an applicable interest rate of 4.50% at June 30, 2022. The Revolving Facility is also subject to a commitment fee of 0.40% on the unused capacity at June 30, 2022.
The JPM Credit Agreement requires the Company to meet certain financial covenants and comply with customary affirmative and negative covenants as listed in the underlying agreement. The Company was in compliance with these covenants at June 30, 2022.
Interest Rate Caps
The Company enters into interest rate caps to mitigate its exposure to interest rate risk by limiting the impact of interest rate changes on cash flows. On May 5, 2022, the Company sold its $300.0 million notional, 2.50% interest rate cap expiring March 8, 2026 and two $100.0 million notional, 3.00% interest rate caps expiring August 13, 2028 for aggregate proceeds of $19.0 million. The Company retained its $300.0 million, 1.50% interest rate cap expiring on March 10, 2024.
The interest rate caps are recorded at an aggregate fair value of $8.6 million and $6.3 million at June 30, 2022 and December 31, 2021, respectively. The interest rate caps are included as a component of other assets on the condensed consolidated balance sheets. The Company recorded a fair value gain of $5.5 million and $21.3 million related to the interest rate caps for the three and six months ended June 30, 2022, respectively, and a fair value loss of $0.8 million for each of the three and six months ended June 30, 2021. The change in fair value of the interest rate caps is included as a component of other income (expense), net in the condensed consolidated statements of comprehensive income (loss).
10. Related Party Transactions
Notes Payable
In September 2021, the Company accelerated recognition of MSI’s maximum contingent earnout and entered into notes payable agreements with each of MSI’s shareholders for a combined principal amount of $61.5 million. The related party notes were subsequently paid in full in April 2022.
Commission Revenue
The Company serves as a broker for Holding Company of the Villages, Inc. (“The Villages”), a significant shareholder, and certain affiliated entities. Commission revenue recorded as a result of transactions with The Villages was $0.6 million and $0.7 million for the three months ended June 30, 2022 and 2021, respectively, and $1.7 million and $1.3 million for the six months ended June 30, 2022 and 2021, respectively.
The Company serves as a broker for certain entities in which a member of our board of directors has a material interest. Commission revenue recorded as a result of these transactions was $0.1 million and $0.2 million for the three and six months ended June 30, 2022, respectively.
Commissions Expense
A brother of Lowry Baldwin, our Board Chair, earned Risk Advisor commissions from the Company of $0.1 million during each of the three months ended June 30, 2022 and 2021 and $0.2 million during each of the six months ended June 30, 2022 and 2021.
Rent Expense
The Company has various agreements to lease office space from wholly-owned subsidiaries of The Villages. Total rent expense incurred with respect to The Villages and its wholly-owned subsidiaries was $0.1 million for each of the three months ended June 30, 2022 and 2021 and $0.2 million and $0.3 million for the six months ended June 30, 2022 and 2021, respectively.
The Company has various agreements to lease office space from other related party entities. Total rent expense incurred with respect to other related parties was $0.9 million and $0.5 million for the three months ended June 30, 2022 and 2021, respectively, and $1.9 million and $1.0 million for the six months ended June 30, 2022 and 2021, respectively. Total right-of-use assets and operating lease liabilities included on the Company’s balance sheet related to these agreements were $16.1 million and $16.4 million, respectively, at June 30, 2022 and $17.9 million and $18.2 million, respectively, at December 31, 2021.
20

11. Share-Based Compensation
The Company has an Omnibus Incentive Plan (the “Omnibus Plan”) and a Partnership Inducement Award Plan (the “Inducement Plan” and collectively, the “Plans”) to motivate and reward Colleagues and other individuals, including those who join the Company through Partnerships, to perform at the highest level and contribute significantly to the Company’s success, thereby furthering the best interests of its shareholders. The Omnibus Plan and the Inducement Plan provide for the Company to make awards of 6,142,862 and 3,000,000 shares of Class A common stock, respectively, at June 30, 2022.
During the six months ended June 30, 2022, the Company made awards of restricted stock, unrestricted stock and performance-based restricted stock units under the Plans to its non-employee directors, Colleagues and executive officers. Shares of unrestricted stock issued to directors during the six months ended June 30, 2022 were vested upon issuance, while restricted stock issued to Colleagues, Risk Advisors and executive officers generally either cliff vest after 3 to 4 years or vest ratably over 3 to 5 years.
The following table summarizes the activity for non-vested awards granted by the Company under the Plans:

|  | Shares |  | Weighted-Average Grant-Date Fair Value Per Share
Outstanding at December 31, 2021 |  | 3,215,731 |  |  | $ | 28.83 |
Granted |  | 853,576 |  |  | 28.57 |
Vested and settled |  | (356,531) |  |  | 27.05 |
Forfeited |  | (54,194) |  |  | 26.00 |
Outstanding at June 30, 2022 |  | 3,658,582 |  |  | 28.67 |

The total fair value of shares that vested and settled under the Plans was $9.6 million and $3.9 million for the six months ended June 30, 2022 and 2021, respectively.
Share-based compensation includes expense recognized for management incentive units and advisor incentives, in addition to issuances under the Plans. The Company recognizes share-based compensation expense for the Plans net of actual forfeitures. The Company recorded total share-based compensation expense of $10.1 million and $4.5 million for the three months ended June 30, 2022 and 2021, respectively, and $17.7 million and $8.1 million for the six months ended June 30, 2022 and 2021, respectively, which is included in commissions, employee compensation and benefits expense in the condensed consolidated statements of comprehensive income (loss).
12. Earnings (Loss) Per Share
Basic earnings per share is computed by dividing net income attributable to BRP Group, Inc. by the weighted-average number of shares of Class A common stock outstanding during the period. Diluted earnings per share is computed giving effect to all potentially dilutive shares of common stock.
During the periods presented, potentially dilutive securities include restricted stock awards and shares of Class B common stock, which can be exchanged (together with a corresponding number of LLC Units) for shares of Class A common stock on a one-for-one basis. The following potentially dilutive securities were excluded from the Company's diluted weighted-average number of shares outstanding calculation for the periods presented as their inclusion would have been anti-dilutive.

|  | For the Three Months Ended June 30, |  | For the Six Months Ended June 30,
|  | 2022 |  | 2021 |  | 2022 |  | 2021
Unvested restricted shares of Class A common stock |  | — |  |  | 1,864,337 |  |  | — |  |  | — |
Shares of Class B common stock |  | 55,442,435 |  |  | 49,575,871 |  |  | 55,442,435 |  |  | 49,575,871 |

The shares of Class B common stock do not share in the earnings or losses attributable to BRP Group, and therefore, are not participating securities. Accordingly, a separate presentation of basic and diluted earnings per share of Class B common stock under the two-class method has not been included.
21

The following is a calculation of the basic and diluted weighted-average number of shares of Class A common stock outstanding and earnings per share for the three and six months ended June 30, 2022 and 2021:

|  | For the Three Months Ended June 30, |  | For the Six Months Ended June 30,
(in thousands, except per share data) |  | 2022 |  | 2021 |  | 2022 |  | 2021
Basic earnings (loss) per share: |  |  |  |  |  |  |  |
Net income (loss) attributable to BRP Group, Inc. |  | $ | 8,642 |  |  | $ | (10,093) |  |  | $ | 31,511 |  |  | $ | 5,213 |
Shares used for basic earnings (loss) per share: |  |  |  |  |  |  |  |
Weighted-average shares of Class A common stock outstanding - basic |  | 56,270 |  | 44,671 |  | 55,997 |  | 44,464
Basic earnings (loss) per share |  | $ | 0.15 |  |  | $ | (0.23) |  |  | $ | 0.56 |  |  | $ | 0.12 |
Diluted earnings (loss) per share: |  |  |  |  |  |  |  |
Net income (loss) attributable to BRP Group, Inc. |  | $ | 8,642 |  |  | $ | (10,093) |  |  | $ | 31,511 |  |  | $ | 5,213 |
Shares used for diluted earnings (loss) per share: |  |  |  |  |  |  |  |
Weighted-average shares of Class A common stock outstanding |  | 56,270 |  |  | 44,671 |  |  | 55,997 |  |  | 44,464 |
Dilutive effect of unvested restricted shares of Class A common stock |  | 3,589 |  |  | — |  |  | 3,357 |  |  | 1,696 |
Weighted-average shares of Class A common stock outstanding - diluted |  | 59,859 |  |  | 44,671 |  |  | 59,354 |  |  | 46,160 |
Diluted earnings (loss) per share |  | $ | 0.14 |  |  | $ | (0.23) |  |  | $ | 0.53 |  |  | $ | 0.11 |

13. Fair Value Measurements
ASC Topic 820, Fair Value Measurement (“Topic 820”) established a framework for measuring fair value. That framework provides a fair value hierarchy that prioritizes the inputs to valuation techniques used to measure fair value. The hierarchy gives the highest priority to unadjusted quoted prices in active markets for identical assets or liabilities (Level 1 measurement) and the lowest priority to unobservable inputs (Level 3 measurement). The three levels of the fair value hierarchy under Topic 820 are described below:
Level 1: Inputs to the valuation methodology are unadjusted quoted prices for identical assets or liabilities in active markets that the Company has the ability to access.
Level 2: Inputs to the valuation methodology are quoted market prices for similar instruments in active markets, quoted prices for identical or similar instruments in markets that are not active, and model-based valuation techniques for which all significant assumptions are observable in the market.
Level 3: Inputs to the valuation methodology are unobservable and significant to the fair value measurement.
The fair value measurement level for assets and liabilities within the fair value hierarchy is based on the lowest level of any input that is significant to the fair value measurement. Valuation techniques used need to maximize the use of observable inputs and minimize the use of unobservable inputs.
Assets and Liabilities Measured at Fair Value on a Recurring Basis
The following table summarizes the Company’s assets and liabilities measured at fair value on a recurring basis within each level of the fair value hierarchy:

(in thousands) |  | June 30, 2022 |  | December 31, 2021
Level 2 |  |  |  |
Interest rate caps |  | $ | 8,569 |  |  | $ | 6,338 |
Level 2 Assets |  | $ | 8,569 |  |  | $ | 6,338 |
Level 3 |  |  |  |
Contingent earnout liabilities |  | $ | 209,996 |  |  | $ | 258,589 |
Level 3 Liabilities |  | $ | 209,996 |  |  | $ | 258,589 |

22

Methodologies used for assets and liabilities measured at fair value on a recurring basis within Level 3 of the fair value hierarchy at June 30, 2022 and December 31, 2021 are based on limited unobservable inputs. These methods may produce a fair value calculation that may not be indicative of the net realizable value or reflective of future fair values. Furthermore, while the Company believes its valuation methods are appropriate and consistent with other market participants, the use of methodologies or assumptions to determine the fair value of certain financial instruments could result in a different fair value measurement at the reporting date.
The fair value of interest rate caps was $8.6 million at June 30, 2022. The fair value of interest rate caps is determined using the market standard methodology of discounting the future expected cash receipts that would occur if variable interest rates rise above the strike rate of the caps. The variable interest rates used in the calculation of projected receipts on the cap are based on an expectation of future interest rates derived from observable market interest rate curves and volatilities.
The fair value of contingent earnout liabilities is based on sales projections for the acquired entities, which are reassessed each reporting period. Based on the Company’s ongoing assessment of the fair value of its contingent earnout liabilities, the Company recorded a net decrease in the estimated fair value of such liabilities of $26.9 million and $32.5 million for the three and six months ended June 30, 2022, respectively. The Company has assessed the maximum estimated exposure to the contingent earnout liabilities to be approximately $1.0 billion at June 30, 2022.
The Company measures contingent earnout liabilities at fair value at each reporting period using significant unobservable inputs classified within Level 3 of the fair value hierarchy. The Company uses a probability weighted value analysis as a valuation technique to convert future estimated cash flows to a single present value amount. The significant unobservable inputs used in the fair value measurements are sales projections over the earnout period, and the probability outcome percentages assigned to each scenario. Significant increases or decreases to either of these inputs would result in a significantly higher or lower liability with a higher liability capped by the contractual maximum of the contingent earnout liabilities. Ultimately, the liability will be equivalent to the amount settled, and the difference between the fair value estimate and amount settled will be recorded in earnings for business combinations, or as a reduction of the cost of the assets acquired for asset acquisitions.
The fair value of the contingent earnout liabilities is based on the present value of the expected future payments to be made to Partners in accordance with the provisions outlined in the respective purchase agreements, which is a Level 3 fair value measurement. In determining fair value, the Company estimates the Partner’s future performance using financial projections developed by management for the Partner and market participant assumptions that were derived for revenue growth, profitability based on EBITDA, the number of rental units tracked or the insured value of sourced homeowners’ insurance. Revenue and EBITDA growth rates generally ranged from 5% to 25% at June 30, 2022 and from 5% to 22% at December 31, 2021. The Company estimates future payments using the earnout formula and performance targets specified in each purchase agreement and these financial projections. These payments are discounted to present value using a risk-adjusted rate that takes into consideration market-based rates of return that reflect the ability of the Partner to achieve the targets. These discount rates generally ranged from 7.50% to 18.00% at June 30, 2022 and from 5.00% to 15.50% at December 31, 2021. Changes in financial projections, market participant assumptions for revenue growth and profitability, or the risk-adjusted discount rate, would result in a change in the fair value of contingent consideration.
23

The following table sets forth a summary of the changes in the fair value of the Company’s contingent earnout liabilities, which are measured at fair value on a recurring basis utilizing Level 3 assumptions in their valuation:

|  | For the Three Months Ended June 30, |  | For the Six Months Ended June 30,
(in thousands) |  | 2022 |  | 2021 |  | 2022 |  | 2021(1)
Balance at beginning of period |  | $ | 227,847 |  |  | $ | 165,283 |  |  | $ | 258,589 |  |  | $ | 164,819 |
Settlement of contingent consideration |  | (4,377) |  |  | (1,430) |  |  | (29,487) |  |  | (1,430) |
Change in fair value of contingent consideration |  | (26,872) |  |  | 13,325 |  |  | (32,504) |  |  | 11,822 |
Fair value of contingent consideration issuances |  | 13,398 |  |  | 1,074 |  |  | 13,398 |  |  | 3,041 |
Balance at end of period |  | $ | 209,996 |  |  | $ | 178,252 |  |  | $ | 209,996 |  |  | $ | 178,252 |

__________
(1) During the six months ended June 30, 2021, the Company recorded measurement period adjustments relating to businesses acquired in the fourth quarter of 2020. These adjustments decreased contingent earnout liabilities by $4.7 million, which offsets issuances of $7.8 million from business combinations for the period.
Fair Value of Other Financial Instruments
The fair value of long-term debt and the revolving line of credit is based on an estimate using a discounted cash flow analysis based on current borrowing rates for similar types of borrowing arrangements. The carrying amount and estimated fair value of long-term debt and the revolving line of credit were as follows:

| Fair Value Hierarchy |  | June 30, 2022 |  | December 31, 2021
|  | Carrying Amount |  | Estimated Fair Value |  | Carrying Amount |  | Estimated Fair Value
Long-term debt(1) | Level 2 |  | $ | 842,368 |  |  | $ | 799,239 |  |  | $ | 846,623 |  |  | $ | 870,120 |
Revolving line of credit | Level 2 |  | 525,000 |  |  | 498,120 |  |  | 35,000 |  |  | 33,968 |

__________
(1) The carrying amount of the long-term debt does not reflect unamortized debt discount and issuance costs of $21.8 million and $23.5 million at June 30, 2022 and December 31, 2021, respectively, which are netted against long-term debt for balance sheet presentation.
14. Commitments and Contingencies
In April 2022, BRP made a commitment to the University of South Florida (“USF”) to donate a total of $5.3 million through October 2028. The gift will provide support for the School of Risk Management and Insurance in the USF Muma College of Business. It is currently anticipated that Lowry Baldwin, our Board Chair, will fund half of the amounts to be donated by BRP.
The Company is involved in various claims and legal actions arising in the ordinary course of business. In the opinion of management, the ultimate disposition of these matters will not have a material adverse effect on the Company’s consolidated financial position, results of operations or liquidity.
15. Segment Information
BRP Group’s business is divided into four Operating Groups: Middle Market, Specialty, MainStreet, and Medicare.
•The Middle Market Operating Group provides expertly-designed commercial risk management, employee benefits solutions and private risk management for mid-to-large size businesses and high net worth individuals, as well as their families.
•The Specialty Operating Group consists of two distinct businesses. Our specialty wholesale broker businesses deliver specialty insurers, professionals, individuals and niche industry businesses expanded access to exclusive specialty markets, capabilities and programs requiring complex underwriting and placement. Specialty also houses our MGA of the Future platform, in which we manufacture proprietary, technology enabled insurance product that is then distributed (in many instances via technology and/or API integrations) internally via our Risk Advisors in Middle Market and MainStreet and externally via select distribution partners, with a focus on sheltered channels where our product delivers speed, ease of use and certainty of execution, an example of which is our national embedded renter’s insurance product sold at point of lease via integrations with property management software providers.
•The MainStreet Operating Group offers personal insurance, commercial insurance and life and health solutions to individuals and businesses in their communities.
24

•The Medicare Operating Group offers consultation for government assistance programs and solutions, including traditional Medicare and Medicare Advantage, to seniors and Medicare-eligible individuals through a network of primarily independent contractor agents. In the Medicare Operating Group, BRP generates commissions and fees in the form of direct bill insurance placement and marketing income. Marketing income is earned through co-branded marketing campaigns with our Insurance Company Partners.
In the Middle Market, MainStreet, and Specialty Operating Groups, the Company generates commissions and fees from insurance placement under both agency bill and direct bill arrangements. In addition, the Company generates profit sharing income in each of those segments based on either the underlying Book of Business or performance, such as loss ratios. In the Middle Market Operating Group only, the Company generates fees from service fee and consulting arrangements. Service fee arrangements are in place with certain customers in lieu of commission arrangements.
In the Medicare Operating Group, the Company generates commissions and fees in the form of direct bill insurance placement and marketing income. Marketing income is earned through co-branded marketing campaigns with the Company’s Insurance Company Partners.
The Company’s chief operating decision maker, the chief executive officer, uses net income (loss) and net income (loss) before interest, taxes, depreciation, amortization, and one-time transactional-related expenses or non-recurring items to manage resources and make decisions about the business.
Summarized financial information concerning the Company’s Operating Groups is shown in the following tables. The Corporate and Other non-reportable segment includes any expenses not allocated to the Operating Groups and corporate-related items, including related party and third-party interest expense. Intersegment revenue and expenses are eliminated through the Corporate and Other column. Service center expenses and other overhead are allocated to the Company’s Operating Groups based on either revenue or headcount as applicable to each expense.

| For the Three Months Ended June 30, 2022
(in thousands) | Middle Market |  | Specialty |  | MainStreet |  | Medicare |  | Corporate and Other |  | Total
Commissions and fees(1) | $ | 131,532 |  |  | $ | 74,301 |  |  | $ | 29,430 |  |  | $ | 6,595 |  |  | $ | (9,398) |  |  | $ | 232,460 |
Net income (loss) | 33,459 |  |  | 11,008 |  |  | 5,359 |  |  | 286 |  |  | (33,519) |  |  | 16,593 |

| For the Three Months Ended June 30, 2021
(in thousands) | Middle Market |  | Specialty |  | MainStreet |  | Medicare |  | Corporate and Other |  | Total
Commissions and fees(2) | $ | 76,109 |  |  | $ | 30,105 |  |  | $ | 8,576 |  |  | $ | 5,152 |  |  | $ | (236) |  |  | $ | 119,706 |
Net income (loss) | (5,898) |  |  | 1,617 |  |  | 972 |  |  | 452 |  |  | (17,584) |  |  | (20,441) |

| For the Six Months Ended June 30, 2022
(in thousands) | Middle Market |  | Specialty |  | MainStreet |  | Medicare |  | Corporate and Other |  | Total
Commissions and fees(1) | $ | 302,935 |  |  | $ | 123,824 |  |  | $ | 38,707 |  |  | $ | 20,276 |  |  | $ | (10,434) |  |  | $ | 475,308 |
Net income (loss) | 88,346 |  |  | 16,326 |  |  | 3,501 |  |  | 4,586 |  |  | (51,327) |  |  | 61,432 |

| For the Six Months Ended June 30, 2021
(in thousands) | Middle Market |  | Specialty |  | MainStreet |  | Medicare |  | Corporate and Other |  | Total
Commissions and fees(2) | $ | 186,664 |  |  | $ | 55,187 |  |  | $ | 16,798 |  |  | $ | 14,604 |  |  | $ | (719) |  |  | $ | 272,534 |
Net income (loss) | 35,981 |  |  | 3,504 |  |  | 2,323 |  |  | 2,769 |  |  | (33,711) |  |  | 10,866 |

__________
(1) During the three and six months ended June 30, 2022, the Middle Market Operating Group recorded intercompany commissions and fees revenue from activity with the Specialty Operating Group of $0.4 million and $0.6 million, respectively; the Specialty Operating Group recorded intercompany commissions and fees revenue from activity with the MainStreet Operating Group and itself of $8.6 million and $8.8 million, respectively; the MainStreet Operating Group recorded intercompany commissions and fees revenue from activity with the Middle Market and Specialty Operating Groups of $0.1 million and $0.2 million, respectively; and the Medicare Operating Group recorded intercompany commissions and fees revenue from activity with itself of $0.3 million and $0.8 million, respectively. These intercompany commissions and fees are eliminated through Corporate and Other.
25

(2) During the three and six months ended June 30, 2021, the Middle Market Operating Group recorded intercompany commissions and fees revenue from activity with the Specialty Operating Group of $0.1 million and $0.5 million, respectively; the MainStreet Operating Group recorded intercompany commissions and fees revenue from activity with the Middle Market Operating Group of less than $0.1 million and less than $0.1 million, respectively; and the Medicare Operating Group recorded intercompany commissions and fees revenue from activity with itself of less than $0.1 million and $0.2 million, respectively. These intercompany commissions and fees are eliminated through Corporate and Other.

(in thousands) | Middle Market |  | Specialty |  | MainStreet |  | Medicare |  | Corporate and Other |  | Total
Total assets at June 30, 2022 | $ | 2,230,111 |  |  | $ | 593,225 |  |  | $ | 464,205 |  |  | $ | 51,552 |  |  | $ | 71,552 |  |  | $ | 3,410,645 |
Total assets at December 31, 2021 | 2,142,485 |  |  | 549,662 |  |  | 61,322 |  |  | 56,472 |  |  | 66,366 |  |  | 2,876,307 |

16. Subsequent Events
On August 1, 2022, the Company purchased certain assets and intellectual and intangible rights and assumed certain liabilities of National Health Plans & Benefits Agency, LLC for upfront consideration of $17.3 million. The Partnership brings to the Company deep expertise in the individual health insurance market. The Company has not yet completed its evaluation and determination of consideration paid, certain assets and liabilities acquired, or treatment of this transaction as either a business combination or asset acquisition in accordance with Topic 805.
26

ITEM 2. MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS
The following discussion and analysis of our financial condition and results of operations should be read in conjunction with our consolidated financial statements and the related notes and other financial information included elsewhere in this Quarterly Report on Form 10-Q and in our Annual Report on Form 10-K for the year ended December 31, 2021 filed with the SEC on March 1, 2022. In addition to historical consolidated financial information, the following discussion contains forward-looking statements that reflect our plans, estimates, and beliefs. Our actual results may differ materially from those discussed in the forward-looking statements as a result of various factors, including those set forth in Part II, Item 1A. Risk Factors and Note Regarding Forward-Looking Statements included elsewhere in this Quarterly Report on Form 10-Q and under Part I, Item 1A. Risk Factors in our Annual Report on Form 10-K filed with the SEC on March 1, 2022.
THE COMPANY
BRP Group, Inc. (“BRP Group,” the “Company,” “we,” “us” or “our”) is an independent insurance distribution firm delivering tailored insurance and risk management insights and solutions that give our Clients the peace of mind to pursue their purpose, passion and dreams. We support our Clients, Colleagues, Insurance Company Partners and communities through the deployment of vanguard resources, technology and capital to drive organic and inorganic growth. When we consistently execute for these key stakeholders, we believe that the outcome is an increase in value for our fifth stakeholder, our shareholders. We are innovating the industry by taking a holistic and tailored approach to risk management, insurance and employee benefits. Our growth plan includes continuing to recruit, train and develop industry leading talent, continuing to add geographic representation, insurance product expertise and end-client industry expertise via our Partnership strategy, and the continued buildout of our MGA of the Future platform, which delivers proprietary, technology-enabled insurance solutions to our internal Risk Advisors as well as to a growing channel of external distribution partners. We are a destination employer supported by an award-winning culture, powered by exceptional people and fueled by industry-leading growth and innovation.
We represent over 1,200,000 Clients across the United States and internationally. Our more than 3,400 Colleagues include over 520 Risk Advisors, who are fiercely independent, relentlessly competitive and “insurance geeks.” We have approximately 125 offices in 22 states, all of which are equipped to provide diversified products and services to empower our Clients at every stage through our four Operating Groups.
•Middle Market provides expertly-designed commercial risk management, employee benefits solutions and private risk management for mid-to-large-size businesses and high net worth individuals, as well as their families.
•MainStreet offers personal insurance, commercial insurance and life and health solutions to individuals and businesses in their communities.
•Medicare offers consultation for government assistance programs and solutions, including traditional Medicare and Medicare Advantage, to seniors and Medicare-eligible individuals through a network of primarily independent contractor agents. In the Medicare Operating Group, we generate commissions and fees in the form of direct bill insurance placement and marketing income. Marketing income is earned through co-branded marketing campaigns with our Insurance Company Partners.
•Specialty consists of two distinct businesses. Our specialty wholesale broker businesses deliver specialty insurers, professionals, individuals and niche industry businesses expanded access to exclusive specialty markets, capabilities and programs requiring complex underwriting and placement. Specialty also houses our MGA of the Future platform, in which we deliver proprietary, technology enabled insurance products that are then distributed (in many instances via technology and/or API integrations) internally via our Risk Advisors in Middle Market and MainStreet and externally via select distribution partners, with a focus on sheltered channels where our products deliver speed, ease of use and certainty of execution, and example of which is our national embedded renter’s insurance product sold at point of lease via integrations with property management software providers.
In 2011, we adopted the “Azimuth” as our corporate constitution. Named after a historical navigation tool used to find “true north,” the Azimuth asserts our core values, business basics and stakeholder promises. The ideals encompassed by the Azimuth support our mission to deliver indispensable, tailored insurance and risk management insights and solutions to our Clients. We strive to be regarded as the preeminent insurance advisory firm fueled by relationships, powered by people and exemplified by Client adoption and loyalty. This type of environment is upheld by the distinct vernacular we use to describe our services and culture. We are a firm, instead of an agency; we have Colleagues, instead of employees; we have Risk Advisors, instead of producers/agents. We serve Clients instead of customers and we refer to our acquisitions as Partnerships. We refer to insurance brokerages that we have acquired, or in the case of asset acquisitions, the producers, as Partners.
27

Seasonality
The insurance brokerage market is seasonal and our results of operations are somewhat affected by seasonal trends. Our Adjusted EBITDA and Adjusted EBITDA Margins are typically highest in the first quarter and lowest in the fourth quarter. This variation is primarily due to fluctuations in our revenues, while overhead remains consistent throughout the year. Our revenues are generally highest in the first quarter due to the impact of contingent payments received in the first quarter from Insurance Company Partners that we cannot readily estimate before receipt without the risk of significant reversal and a higher degree of first quarter policy commencements and renewals in Medicare and certain Middle Market lines of business such as employee benefits and commercial. In addition, a higher proportion of our first quarter revenue is derived from our highest margin businesses. As discussed further below, the ongoing COVID-19 pandemic may continue to skew these general trends due to reduced amounts of new business and reductions in business from existing Clients related to the pandemic.
Partnerships can significantly impact Adjusted EBITDA and Adjusted EBITDA Margins in a given year and may increase the amount of seasonality within the business, especially results attributable to Partnerships that have not been fully integrated into our business or owned by us for a full year.
PARTNERSHIPS
We utilize strategic acquisitions, which we refer to as Partnerships, to complement and expand our business. We source Partnerships through proprietary deal flow, competitive auctions and cultivated industry relationships. We are currently considering Partnership opportunities in all of our Operating Groups, including businesses to complement or expand our MGA of the Future that are valued at higher purchase price multiples than businesses in our other Operating Groups.
The financial impact of Partnerships may affect the comparability of our results from period to period. Our acquisition strategy also entails certain risks, including the risks that we may not be able to successfully source, value, close, integrate and effectively manage businesses that we acquire. To mitigate that risk, we have a professional team focused on finding new Partners and integrating new Partnerships. We plan to execute on numerous Partnerships annually as it is a key pillar in our long-term growth strategy over the next seven years.
We completed two Partnerships for an aggregate purchase price of $396.4 million during the six months ended June 30, 2022 and five Partnerships for an aggregate purchase price of $41.1 million during the six months ended June 30, 2021. Partnerships completed during 2022 added $4.4 million of premiums, commissions and fees receivable, $212.2 million of intangible assets and $183.0 million of goodwill to the condensed consolidated balance sheet.
We entered into Amendment No. 5 to the JPM Credit Agreement in March 2022 for an upsize of the aggregate principal amount of the revolving credit facility thereunder from $475.0 million to $600.0 million. This transaction provided us incremental capacity to assist in funding our Partnership pipeline with a reduction in our cost of capital.
NOVEL CORONAVIRUS (COVID-19)
The impact of the COVID-19 pandemic, including changes in consumer behavior, pandemic fears, and market downturns, as well as restrictions on business and individual activities, has created significant volatility in the global economy and led to severe restrictions on the level of economic activity around the world.
Although COVID-19 vaccines are now broadly distributed and administered, there remains significant uncertainty concerning the magnitude of the impact and the duration of the COVID-19 pandemic. As new strains of COVID-19 develop, we may continue to experience disruptions to our business, including due to a reduction in our Clients` insurable exposure units and a delay in cash payments to us from our Clients or Insurance Company Partners. Further, the impacts of inflation on our and our Clients` businesses and the broader economy, which may be exacerbated by the economic recovery from the COVID-19 pandemic, may also impact our financial condition and results of operations.
In addition, the uncertainties associated with the protective and preventive measures being put in place or recommended by both governmental entities and other businesses, among other uncertainties, may result in delays or modifications to our plans and initiatives.
28

Our Clients and Colleagues are our first priority and we have taken steps to ensure their safety by implementing alternative working arrangement, with a significant part of our Colleagues working in remote or hybrid environments. As we began a phased reopening of our U.S. offices in 2021, we provided guidelines on return to the office depending on the level of virus containment and local health and safety regulations in each geography. This has created and may continue to create additional risks and operational challenges and may require us to make additional investments of time and resources across our business, including to design, implement and enforce new workplace health and safety protocols, as well as investments in our IT systems to support a working environment that encompasses a mix of remote and in-person arrangements.
During the pandemic, we have also funded the BRP True North Colleague Fund to assist with relief for COVID-19 and other qualifying disasters for our Colleagues experiencing extraordinary hardship and are currently matching Colleague donations dollar-for dollar.
We intend to continue to execute on our strategic plans and operational initiatives during the pandemic. However, given the uncertainty regarding the spread and severity of COVID-19 and its variant strains, the duration and scope of government measures, the nature of societal responses and the adverse effects on the national and global economy, the related financial impact on our business cannot be accurately predicted at this time. See Part I, Item 1A. “Risk Factors—The continued adverse effects of the COVID-19 pandemic and an indeterminate recovery period could result in declines in business and increases in claims that could adversely affect our business, financial condition and results of operations” in our Annual Report on Form 10-K filed with the SEC on March 1, 2022.
RESULTS OF OPERATIONS FOR THE THREE AND SIX MONTHS ENDED JUNE 30, 2022 AND 2021
The following discussion and analysis of our financial condition and results of operations should be read in conjunction with our condensed consolidated financial statements for the three and six months ended June 30, 2022 and the related notes and other financial information included elsewhere in this report. In addition to historical financial information, the following discussion and analysis contains forward-looking statements that involve risks, uncertainties and assumptions. Our actual results and timing of selected events may differ materially from those anticipated in these forward-looking statements as a result of many factors, including those discussed under Part I, Item 1A. Risk Factors in our Annual Report on Form 10-K filed with the SEC on March 1, 2022.
29

The following is a discussion of our consolidated results of operations for the three and six months ended June 30, 2022 and 2021.

| For the Three Months Ended June 30, |  |  |  | For the Six Months Ended June 30, |  |
(in thousands) | 2022 |  | 2021 |  | Variance |  | 2022 |  | 2021 |  | Variance
Revenues: |  |  |  |  |  |  |  |  |  |  |
Commissions and fees | $ | 232,460 |  |  | $ | 119,706 |  |  | $ | 112,754 |  |  | $ | 475,308 |  |  | $ | 272,534 |  |  | $ | 202,774 |
Operating expenses: |  |  |  |  |  |  |  |  |  |  |
Commissions, employee compensation and benefits | 172,848 |  |  | 89,065 |  |  | 83,783 |  |  | 326,598 |  |  | 178,440 |  |  | 148,158 |
Other operating expenses | 40,770 |  |  | 19,537 |  |  | 21,233 |  |  | 77,212 |  |  | 36,412 |  |  | 40,800 |
Amortization expense | 19,170 |  |  | 10,742 |  |  | 8,428 |  |  | 36,732 |  |  | 21,279 |  |  | 15,453 |
Change in fair value of contingent consideration | (26,872) |  |  | 13,325 |  |  | (40,197) |  |  | (32,504) |  |  | 11,822 |  |  | (44,326) |
Depreciation expense | 1,105 |  |  | 573 |  |  | 532 |  |  | 2,093 |  |  | 1,167 |  |  | 926 |
Total operating expenses | 207,021 |  |  | 133,242 |  |  | 73,779 |  |  | 410,131 |  |  | 249,120 |  |  | 161,011 |
Operating income (loss) | 25,439 |  |  | (13,536) |  |  | 38,975 |  |  | 65,177 |  |  | 23,414 |  |  | 41,763 |
Other income (expense): |  |  |  |  |  |  |  |  |  |  |
Interest expense, net | (14,632) |  |  | (5,848) |  |  | (8,784) |  |  | (24,982) |  |  | (11,491) |  |  | (13,491) |
Other income (expense), net | 5,786 |  |  | (1,057) |  |  | 6,843 |  |  | 21,237 |  |  | (1,057) |  |  | 22,294 |
Total other expense | (8,846) |  |  | (6,905) |  |  | (1,941) |  |  | (3,745) |  |  | (12,548) |  |  | 8,803 |
Net income (loss) | 16,593 |  |  | (20,441) |  |  | 37,034 |  |  | 61,432 |  |  | 10,866 |  |  | 50,566 |
Less: net income (loss) attributable to noncontrolling interests | 7,951 |  |  | (10,348) |  |  | 18,299 |  |  | 29,921 |  |  | 5,653 |  |  | 24,268 |
Net income (loss) attributable to BRP Group, Inc. | $ | 8,642 |  |  | $ | (10,093) |  |  | $ | 18,735 |  |  | $ | 31,511 |  |  | $ | 5,213 |  |  | $ | 26,298 |

Commissions and Fees
We earn commissions and fees by facilitating the arrangement between Insurance Company Partners and individuals or businesses for the carrier to provide insurance to the insured party. Our commissions and fees are usually a percentage of the premium paid by the insured and generally depends on the type of insurance, the particular Insurance Company Partner and the nature of the services provided. Under certain arrangements with Clients, we earn pre-negotiated service fees in lieu of commissions. Additionally, we may also receive from Insurance Company Partners a profit-sharing commission, or straight override, which represent forms of variable consideration associated with the placement of coverage and are based primarily on underwriting results, but may also contain considerations for volume, growth or retention.
Commissions and fees increased $112.8 million and $202.8 million for the three and six months ended June 30, 2022 as compared to the same period of 2021, respectively. This increase was related to amounts attributable to Partners acquired during 2021 and 2022 prior to their having reached the twelve-month owned mark (such amounts, the “Partnership Contribution”) and organic growth. The Partnership Contribution accounted for $84.2 million and $149.0 million of the increase to commissions and fees for the quarter and year-to-date periods, respectively, and organic growth accounted for $28.6 million and $53.8 million of the increase for the quarter and year-to-date periods, respectively.
30

Major Sources of Commissions and Fees
The following table sets forth our commissions and fees by major source for the periods indicated:

| For the Three Months Ended June 30, |  |  |  | For the Six Months Ended June 30, |  |
(in thousands) | 2022 |  | 2021 |  | Variance |  | 2022 |  | 2021 |  | Variance
Direct bill revenue | $ | 93,534 |  |  | $ | 50,358 |  |  | $ | 43,176 |  |  | $ | 225,194 |  |  | $ | 144,863 |  |  | $ | 80,331 |
Agency bill revenue | 89,015 |  |  | 47,293 |  |  | 41,722 |  |  | 162,192 |  |  | 82,633 |  |  | 79,559 |
Profit-sharing revenue | 19,366 |  |  | 8,175 |  |  | 11,191 |  |  | 34,378 |  |  | 18,467 |  |  | 15,911 |
Consulting and service fee revenue | 12,188 |  |  | 7,570 |  |  | 4,618 |  |  | 26,525 |  |  | 14,577 |  |  | 11,948 |
Policy fee and installment fee revenue | 13,419 |  |  | 4,792 |  |  | 8,627 |  |  | 19,127 |  |  | 9,268 |  |  | 9,859 |
Other income | 4,938 |  |  | 1,518 |  |  | 3,420 |  |  | 7,892 |  |  | 2,726 |  |  | 5,166 |
Total commissions and fees | $ | 232,460 |  |  | $ | 119,706 |  |  | $ | 112,754 |  |  | $ | 475,308 |  |  | $ | 272,534 |  |  | $ | 202,774 |

Direct bill revenue represents commission revenue earned by providing insurance placement services to Clients, primarily for private risk management, commercial risk management, employee benefits and Medicare insurance types. Direct bill revenue increased by $43.2 million and $80.3 million for the three and six months ended June 30, 2022 as compared to the same periods of 2021, respectively. The Partnership Contribution accounted for $36.5 million and $62.1 million of the increase to direct bill revenue for the quarter and year-to-date periods, respectively. Organic growth for direct bill revenue was $6.7 million and $18.2 million for the quarter and year-to-date periods, respectively.
Agency bill revenue primarily represents commission revenue earned by providing insurance placement services to clients wherein we act as an agent on behalf of the Client. Agency bill revenue increased $41.7 million and $79.6 million for the three and six months ended June 30, 2022 as compared to the same periods of 2021, respectively. The Partnership Contribution accounted for $34.4 million and $62.2 million of the increase to agency bill revenue for the quarter and year-to-date periods, respectively. Organic growth for agency bill revenue was $7.3 million and $17.4 million for the quarter and year-to-date periods, respectively.
Profit-sharing revenue represents bonus-type or contingent revenue that is earned by us as a sales incentive provided by certain Insurance Company Partners. Profit-sharing revenue increased $11.2 million and $15.9 million for the three and six months ended June 30, 2022 as compared to the same periods of 2021, respectively, as a result of the Partnership Contribution of $5.8 million and $9.4 million, respectively, and organic growth of $5.4 million and $6.5 million, respectively. Profit-sharing revenue was affected by higher loss ratios in our Middle Market and MainStreet Operating Groups, which is particularly acute in the Florida homeowners marketplace.
Consulting and service fee revenue represents fees received in lieu of a commission and specialty insurance consulting revenue. Consulting and service fee revenue increased $4.6 million and $11.9 million for the three and six months ended June 30, 2022 as compared to the same periods of 2021, respectively, as a result of the Partnership Contribution of $3.5 million and $9.6 million, respectively, and organic growth of $1.1 million and $2.3 million, respectively.
Policy fee and installment fee revenue represents revenue earned for acting in the capacity of an MGA and providing payment processing and services and other administrative functions on behalf of Insurance Company Partners. Policy fee and installment fee revenue increased $8.6 million and $9.9 million during the three and six months ended June 30, 2022 as compared to the same periods of 2021, respectively, largely due to organic growth. These fees are generated by our Specialty Operating Group.
Other income consists of Medicare marketing income that is based on agreed-upon cost reimbursement for fulfilling specific targeted marketing campaigns in addition to other ancillary income and premium financing income generated across all Operating Groups. Other income increased $3.4 million and $5.2 million for the three and six months ended June 30, 2022 as compared to the same periods of 2021, respectively.
Commissions, Employee Compensation and Benefits
Commissions, employee compensation and benefits is our largest expense. It consists of (a) base compensation comprising salary, bonuses and benefits paid and payable to Colleagues, commissions paid to Colleagues and outside commissions paid to others; and (b) equity-based compensation associated with the grants of restricted and unrestricted stock awards to senior management, Colleagues, Risk Advisors and directors. We expect to continue to experience a general rise in commissions, employee compensation and benefits expense commensurate with expected growth in our revenue and headcount. We operate in competitive markets for human capital and need to maintain competitive compensation levels as we expand geographically and create new products and services.
31

Our compensation arrangements with our employees contain significant bonus or commission components driven by the results of our operations. Therefore, as we grow commissions and fees, we expect compensation costs to rise.
Commissions, employee compensation and benefits expenses increased $83.8 million and $148.2 million for the three and six months ended June 30, 2022 as compared to the same periods of 2021, respectively. The Partnership Contribution accounted for $45.4 million and $82.3 million of the increase to commissions, employee compensation and benefits for the quarter and year-to-date periods, respectively. Share-based compensation expense increased $5.6 million and $9.6 million, respectively, as a result of equity grants awarded to all newly hired Colleagues, including those who joined us through Partnerships, and grants to reward Colleagues, including members of senior management. The remaining increase in commissions, employee compensation and benefits expense can be attributed to higher commissions expense relating to our organic growth and higher compensation and benefits relating to hiring to support our growth.
Other Operating Expenses
Other operating expenses include travel, accounting, legal and other professional fees, placement fees, rent, office expenses and other costs associated with our operations. Our occupancy-related costs and professional services expenses, in particular, generally increase or decrease in relative proportion to the number of our employees and the overall size and scale of our business operations.
Other operating expenses increased $21.2 million for the three months ended June 30, 2022 as compared to the same period of 2021, which was primarily attributable to increases in professional fees of $6.7 million relating to Partnership transactions, debt raises and public filings, dues and subscriptions of $4.6 million from our investment in technology to support our growth, rent expense of $3.6 million relating to expansion of our operating locations, colleague education and welfare of $3.2 million relating to investments in our Colleagues, travel and entertainment of $2.4 million relating to Partnership travel and lodging costs, licenses and taxes of $1.6 million relating to revenue growth, and advertising and marketing and repairs and maintenance of $1.4 million each. These increases were partially offset by a decrease in consulting fees of $6.3 million.
Other operating expenses increased $40.8 million for the six months ended June 30, 2022 as compared to the same period of 2021, which was primarily attributable to increases in professional fees of $11.5 million relating to Partnership transactions, debt raises and public filings, dues and subscriptions of $6.9 million from our investment in technology to support our growth, rent expense of $5.7 million relating to expansion of our operating locations, travel and entertainment of $4.5 million relating to Partnership travel and lodging costs, colleague education and welfare of $4.5 million relating to investments in our Colleagues, licenses and taxes of $3.0 million relating to revenue growth, advertising and marketing of $2.6 million and repairs and maintenance of $2.4 million. These increases were partially offset by a decrease in consulting fees of $5.5 million.
Amortization Expense
Amortization expense increased $8.4 million and $15.5 million for the three and six months ended June 30, 2022 as compared to the same period of 2021, respectively, which was driven by amortization of intangible assets recorded in connection with Partnerships over the past twelve months.
Change in Fair Value of Contingent Consideration
Change in fair value of contingent consideration was a $26.9 million gain for the three months ended June 30, 2022 as compared to a $13.3 million loss for the same period of 2021. Change in fair value of contingent consideration was a $32.5 million gain for the six months ended June 30, 2022 as compared to a $11.8 million loss for the same period of 2021. The change in fair value of contingent consideration for 2022 was impacted by high market volatility, rising interest rates and changes in growth trends of certain partners, which resulted in the reduction of contingent earnout consideration values.
Depreciation Expense
Depreciation expense increased $0.5 million and $0.9 million for the three and six months ended June 30, 2022 as compared to the same periods of 2021, respectively, which was driven by our growth.
Interest Expense, Net
Interest expense, net increased $8.8 million and $13.5 million for the three and six months ended June 30, 2022 as compared to the same periods of 2021, respectively, resulting from higher average borrowings outstanding, offset in part by lower average interest rates, during 2022.
32

Other Income, Net
Other income, net was $5.8 million and $21.2 million for the three and six months ended June 30, 2022, primarily as a result of a fair value gain of $5.5 million and $21.3 million recorded for our interest rate caps during the quarter and year-to-date periods, respectively, in connection with rising interest rates and market estimates for future rate increases.
NON-GAAP FINANCIAL MEASURES
Adjusted EBITDA, Adjusted EBITDA Margin, Organic Revenue, Organic Revenue Growth, Adjusted Net Income and Adjusted Diluted Earnings Per Share (“EPS”), are not measures of financial performance under GAAP and should not be considered substitutes for GAAP measures, including commissions and fees (for Organic Revenue and Organic Revenue Growth), net income (loss) (for Adjusted EBITDA and Adjusted EBITDA Margin) net income (loss) attributable to BRP Group, Inc. (for Adjusted Net Income) or diluted earnings (loss) per share (for Adjusted Diluted EPS), which we consider to be the most directly comparable GAAP measures. These non-GAAP financial measures have limitations as analytical tools, and when assessing our operating performance, you should not consider these non-GAAP financial measures in isolation or as substitutes for commissions and fees, net income (loss), net income (loss) attributable to BRP Group, Inc. or other consolidated income statement data prepared in accordance with GAAP. Other companies in our industry may define or calculate these non-GAAP financial measures differently than we do, and accordingly these measures may not be comparable to similarly titled measures used by other companies.
We define Adjusted EBITDA as net income (loss) before interest, taxes, depreciation, amortization, change in fair value of contingent consideration and certain items of income and expense, including share-based compensation expense, transaction-related expenses related to Partnerships, severance, and certain non-recurring costs, including those related to raising capital. We believe that Adjusted EBITDA is an appropriate measure of operating performance because it eliminates the impact of expenses that do not relate to business performance, and that the presentation of this measure enhances an investor’s understanding of our financial performance.
Adjusted EBITDA Margin is Adjusted EBITDA divided by commissions and fees. Adjusted EBITDA Margin is a key metric used by management and our board of directors to assess our financial performance. We believe that Adjusted EBITDA Margin is an appropriate measure of operating performance because it eliminates the impact of expenses that do not relate to business performance, and that the presentation of this measure enhances an investor’s understanding of our financial performance. We believe that Adjusted EBITDA Margin is helpful in measuring profitability of operations on a consolidated level.
Adjusted EBITDA and Adjusted EBITDA Margin have important limitations as analytical tools. For example, Adjusted EBITDA and Adjusted EBITDA Margin:
•do not reflect any cash capital expenditure requirements for the assets being depreciated and amortized that may have to be replaced in the future;
•do not reflect changes in, or cash requirements for, our working capital needs;
•do not reflect the impact of certain cash charges resulting from matters we consider not to be indicative of our ongoing operations;
•do not reflect the interest expense or the cash requirements necessary to service interest or principal payments on our debt;
•do not reflect share-based compensation expense and other non-cash charges; and
•exclude certain tax payments that may represent a reduction in cash available to us.
We calculate Organic Revenue Growth based on commissions and fees for the relevant period by excluding the first twelve months of commissions and fees generated from new Partners. Organic Revenue Growth is the change in Organic Revenue period-to-period, with prior period results adjusted to include commissions and fees that were excluded from Organic Revenue in the prior period because the relevant Partners had not yet reached the twelve-month owned mark, but which have reached the twelve-month owned mark in the current period. For example, revenues from a Partner acquired on June 1, 2021 are excluded from Organic Revenue for 2021. However, after June 1, 2022, results from June 1, 2021 to December 31, 2021 for such Partners are compared to results from June 1, 2022 to December 31, 2022 for purposes of calculating Organic Revenue Growth in 2022. Organic Revenue Growth is a key metric used by management and our board of directors to assess our financial performance. We believe that Organic Revenue and Organic Revenue Growth are appropriate measures of operating performance as they allow investors to measure, analyze and compare growth in a meaningful and consistent manner.
33

Adjusted Net Income is presented for the purpose of calculating Adjusted Diluted EPS. We define Adjusted Net Income as net income (loss) attributable to BRP Group, Inc. adjusted for depreciation, amortization, change in fair value of contingent consideration and certain items of income and expense, including share-based compensation expense, transaction-related expenses related to Partnerships, severance, and certain non-recurring costs that, in the opinion of management, significantly affect the period-over-period assessment of operating results, and the related tax effect of those adjustments. We believe that Adjusted Net Income is an appropriate measure of operating performance because it eliminates the impact of expenses that do not relate to business performance.
Adjusted Diluted EPS measures our per share earnings excluding certain expenses as discussed above and assuming all shares of Class B common stock were exchanged for Class A common stock. Adjusted Diluted EPS is calculated as Adjusted Net Income divided by adjusted dilutive weighted-average shares outstanding. We believe Adjusted Diluted EPS is useful to investors because it enables them to better evaluate per share operating performance across reporting periods.
Adjusted EBITDA and Adjusted EBITDA Margin
The following table reconciles Adjusted EBITDA and Adjusted EBITDA Margin to net income, which we consider to be the most directly comparable GAAP financial measure:

|  | For the Three Months Ended June 30, |  | For the Six Months Ended June 30,
(in thousands, except percentages) |  | 2022 |  | 2021 |  | 2022 |  | 2021
Commissions and fees |  | $ | 232,460 |  |  | $ | 119,706 |  |  | $ | 475,308 |  |  | $ | 272,534 |
Net income (loss) |  | $ | 16,593 |  |  | $ | (20,441) |  |  | $ | 61,432 |  |  | $ | 10,866 |
Adjustments to net income (loss): |  |  |  |  |  |  |  |
Amortization expense |  | 19,170 |  |  | 10,742 |  |  | 36,732 |  |  | 21,279 |
Change in fair value of contingent consideration |  | (26,872) |  |  | 13,325 |  |  | (32,504) |  |  | 11,822 |
Interest expense, net |  | 14,632 |  |  | 5,848 |  |  | 24,982 |  |  | 11,491 |
Change in fair value of interest rate caps |  | (5,459) |  |  | 825 |  |  | (21,269) |  |  | 825 |
Share-based compensation |  | 10,113 |  |  | 4,545 |  |  | 17,677 |  |  | 8,087 |
Transaction-related Partnership expenses |  | 9,208 |  |  | 3,225 |  |  | 17,424 |  |  | 5,670 |
Depreciation expense |  | 1,105 |  |  | 573 |  |  | 2,093 |  |  | 1,167 |
Severance |  | 653 |  |  | — |  |  | 875 |  |  | — |
Other(1) |  | 3,341 |  |  | 1,412 |  |  | 7,974 |  |  | 2,271 |
Adjusted EBITDA |  | $ | 42,484 |  |  | $ | 20,054 |  |  | $ | 115,416 |  |  | $ | 73,478 |
Adjusted EBITDA Margin |  | 18 | % |  | 17 | % |  | 24 | % |  | 27 | %

__________
(1) Other addbacks to Adjusted EBITDA include certain expenses that are considered to be non-recurring or non-operational, including certain recruiting costs, remediation efforts, professional fees and litigation costs, and bonuses.
Organic Revenue and Organic Revenue Growth
The following table reconciles Organic Revenue and Organic Revenue Growth to commissions and fees, which we consider to be the most directly comparable GAAP financial measure:

|  | For the Three Months Ended June 30, |  | For the Six Months Ended June 30,
(in thousands, except percentages) |  | 2022 |  | 2021 |  | 2022 |  | 2021
Commissions and fees |  | $ | 232,460 |  |  | $ | 119,706 |  |  | $ | 475,308 |  |  | $ | 272,534 |
Partnership commissions and fees(1) |  | (84,186) |  |  | (51,893) |  |  | (148,963) |  |  | (143,108) |
Organic Revenue |  | $ | 148,274 |  |  | $ | 67,813 |  |  | $ | 326,345 |  |  | $ | 129,426 |
Organic Revenue Growth(2) |  | $ | 28,630 |  |  | $ | 16,482 |  |  | $ | 53,811 |  |  | $ | 23,929 |
Organic Revenue Growth %(2) |  | 24 | % |  | 32 | % |  | 20 | % |  | 23 | %

__________
(1) Includes the first twelve months of such commissions and fees generated from newly acquired Partners.
34

(2) Organic Revenue Growth for the three and six months ended June 30, 2021 used to calculate Organic Revenue for the three and six months ended June 30, 2022 was $119.6 million and $272.5 million, respectively, which is adjusted to reflect revenues from Partnerships that reached the twelve-month owned mark during the three and six months ended June 30, 2022.
Adjusted Net Income and Adjusted Diluted EPS
The following table reconciles Adjusted Net Income to net income attributable to BRP Group, Inc. and reconciles Adjusted Diluted EPS to diluted earnings per share, which we consider to be the most directly comparable GAAP financial measures:

|  | For the Three Months Ended June 30, |  | For the Six Months Ended June 30,
(in thousands, except per share data) |  | 2022 |  | 2021(1) |  | 2022 |  | 2021(1)
Net income (loss) attributable to BRP Group, Inc. |  | $ | 8,642 |  |  | $ | (10,093) |  |  | $ | 31,511 |  |  | $ | 5,213 |
Net income (loss) attributable to noncontrolling interests |  | 7,951 |  |  | (10,348) |  |  | 29,921 |  |  | 5,653 |
Amortization expense |  | 19,170 |  |  | 10,742 |  |  | 36,732 |  |  | 21,279 |
Change in fair value of contingent consideration |  | (26,872) |  |  | 13,325 |  |  | (32,504) |  |  | 11,822 |
Change in fair value of interest rate caps |  | (5,459) |  |  | 825 |  |  | (21,269) |  |  | 825 |
Share-based compensation |  | 10,113 |  |  | 4,545 |  |  | 17,677 |  |  | 8,087 |
Transaction-related Partnership expenses |  | 9,208 |  |  | 3,225 |  |  | 17,424 |  |  | 5,670 |
Amortization of deferred financing costs |  | 1,188 |  |  | 750 |  |  | 2,474 |  |  | 1,443 |
Depreciation |  | 1,105 |  |  | 573 |  |  | 2,093 |  |  | 1,167 |
Severance |  | 653 |  |  | — |  |  | 875 |  |  | — |
Other(2) |  | 3,341 |  |  | 1,412 |  |  | 7,974 |  |  | 2,271 |
Adjusted pre-tax income |  | 29,040 |  |  | 14,956 |  |  | 92,908 |  |  | 63,430 |
Adjusted income taxes(3) |  | 2,875 |  |  | 1,481 |  |  | 9,198 |  |  | 6,280 |
Adjusted Net Income |  | $ | 26,165 |  |  | $ | 13,475 |  |  | $ | 83,710 |  |  | $ | 57,150 |
Weighted-average shares of Class A common stock outstanding - diluted |  | 59,859 |  |  | 44,671 |  |  | 59,354 |  |  | 46,160 |
Dilutive effect of unvested restricted shares of Class A common stock |  | — |  |  | 1,862 |  |  | — |  |  | — |
Exchange of Class B shares(4) |  | 55,864 |  |  | 49,600 |  |  | 56,065 |  |  | 49,694 |
Adjusted dilutive weighted-average shares outstanding |  | 115,723 |  |  | 96,133 |  |  | 115,419 |  |  | 95,854 |
Adjusted Diluted EPS |  | $ | 0.23 |  |  | $ | 0.14 |  |  | $ | 0.73 |  |  | $ | 0.60 |
Diluted earnings (loss) per share |  | $ | 0.14 |  |  | $ | (0.23) |  |  | $ | 0.53 |  |  | $ | 0.11 |
Effect of exchange of Class B shares and net income (loss) attributable to noncontrolling interests per share |  | — |  |  | 0.02 |  |  | — |  |  | — |
Other adjustments to earnings (loss) per share |  | 0.11 |  |  | 0.37 |  |  | 0.28 |  |  | 0.56 |
Adjusted income taxes per share |  | (0.02) |  |  | (0.02) |  |  | (0.08) |  |  | (0.07) |
Adjusted Diluted EPS |  | $ | 0.23 |  |  | $ | 0.14 |  |  | $ | 0.73 |  |  | $ | 0.60 |

___________
(1) Calculation was adjusted in the fourth quarter of 2021 to include depreciation. Prior year amounts have been conformed to current year presentation.
(2) Other addbacks to Adjusted Net Income include certain expenses that are considered to be non-recurring or non-operational, including certain recruiting costs, remediation efforts, professional fees and litigation costs, and bonuses.
(3) Represents corporate income taxes at assumed effective tax rate of 9.9% applied to adjusted pre-tax income.
(4) Assumes the full exchange of Class B shares for Class A common stock pursuant to the Amended LLC Agreement.
35

OPERATING GROUP RESULTS
Commissions and Fees
In the Middle Market, MainStreet and Specialty Operating Groups, we generate commissions and fees from insurance placement under both agency bill and direct bill arrangements. In addition, we generate profit-sharing income in each of those segments based on either the underlying Book of Business or performance, such as loss ratios. In the Middle Market and Specialty Operating Groups, we generate fees from service fee and consulting arrangements. Service fee arrangements are in place with certain customers in lieu of commission arrangements.
In the Specialty Operating Group, we generate policy fee and installment fee revenue for acting in the capacity of an MGA and fulfilling certain services on behalf of Insurance Company Partners.
In the Medicare Operating Group, we generate commissions and fees in the form of direct bill insurance placement and marketing income. Marketing income is earned through co-branded marketing campaigns with our Insurance Company Partners.
The following table sets forth our commissions and fees by Operating Group and for Corporate and Other by amount and as a percentage of our commissions and fees:

Commissions and Fees by Operating Group (in thousands, except percentages)
| For the Three Months Ended June 30, |  |  |  | For the Six Months Ended June 30, |  |
| 2022 | 2021 | Variance |  | 2022 | 2021 | Variance
Operating Group | Amount | Percent of Business | Amount | Percent of Business | Amount | % |  | Amount | Percent of Business | Amount | Percent of Business | Amount | %
Middle Market | $ | 131,532 |  | 56 | % | $ | 76,109 |  | 64 | % | $ | 55,423 |  | 73 | % |  | $ | 302,935 |  | 64 | % | $ | 186,664 |  | 68 | % | $ | 116,271 |  | 62 | %
Specialty | 74,301 |  | 32 | % | 30,105 |  | 25 | % | 44,196 |  | 147 | % |  | 123,824 |  | 26 | % | 55,187 |  | 20 | % | 68,637 |  | 124 | %
MainStreet | 29,430 |  | 13 | % | 8,576 |  | 7 | % | 20,854 |  | 243 | % |  | 38,707 |  | 8 | % | 16,798 |  | 6 | % | 21,909 |  | 130 | %
Medicare | 6,595 |  | 3 | % | 5,152 |  | 4 | % | 1,443 |  | 28 | % |  | 20,276 |  | 4 | % | 14,604 |  | 5 | % | 5,672 |  | 39 | %
Corporate and Other | (9,398) |  | (4) | % | (236) |  | — | % | (9,162) |  | n/m |  | (10,434) |  | (2) | % | (719) |  | — | % | (9,715) |  | n/m
| $ | 232,460 |  |  | $ | 119,706 |  |  | $ | 112,754 |  |  |  | $ | 475,308 |  |  | $ | 272,534 |  |  | $ | 202,774 |  |

__________
n/m not meaningful
Commissions and fees for our Middle Market Operating Group increased $55.4 million for the second quarter of 2022 as compared to the same period of 2021 as a result of the Partnership Contribution of $46.8 million and organic growth of $8.6 million. Organic growth included $4.6 million related to base commissions and fees and $4.0 million related to contingent revenue.
Commissions and fees for our Middle Market Operating Group increased $116.3 million for the first half of 2022 as compared to the same period of 2021 as a result of the Partnership Contribution of $93.9 million and organic growth of $22.4 million. Organic growth included $18.7 million related to base commissions and fees and $4.2 million related to contingent revenue.
Commissions and fees for our Specialty Operating Group increased $44.2 million for the second quarter of 2022 as compared to the same period of 2021 as a result of the Partnership Contribution of $28.2 million and organic growth of $16.0 million, which is attributable to growth in our renter’s and homeowner’s insurance products and base commissions.
Commissions and fees for our Specialty Operating Group increased $68.6 million for the first half of 2022 as compared to the same period of 2021 as a result of the Partnership Contribution of $44.9 million and organic growth of $23.7 million, which is primarily attributable to growth in our renter’s and homeowner’s insurance products and base commissions.
Commissions and fees for our MainStreet Operating Group increased $20.9 million for the second quarter of 2022 as compared to the same period of 2021 as a result of the Partnership Contribution of $18.1 million and organic growth of $2.8 million, primarily related to base commissions and fees.
Commissions and fees for our MainStreet Operating Group increased $21.9 million for the first half of 2022 as compared to the same period of 2021 as a result of the Partnership Contribution of $18.0 million and organic growth of $3.9 million, primarily related to base commissions and fees.
36

Commissions and fees for our Medicare Operating Group increased $1.4 million for the second quarter of 2022 as compared to the same period of 2021 as a result of organic growth of $1.2 million and the Partnership Contribution of $0.2 million.
Commissions and fees for our Medicare Operating Group increased $5.7 million for the first half of 2022 as compared to the same period of 2021 as a result of organic growth of $3.7 million and the Partnership Contribution of $2.0 million.
Revenue reported for Corporate and Other relates to the elimination of intercompany revenue. During the second quarter of 2022, the Middle Market Operating Group recorded intercompany commissions and fees from activity with the Specialty Operating Group of $0.4 million; the Specialty Operating Group recorded intercompany commissions and fees revenue from activity with the MainStreet Operating Group and itself of $8.6 million; the MainStreet Operating Group recorded intercompany commissions and fees from activity with the Middle Market and Specialty Operating Groups of less than $0.1 million; and the Medicare Operating Group recorded intercompany commissions and fees from activity with itself of $0.3 million. These amounts were eliminated through Corporate and Other.
During the first half of 2022, the Middle Market Operating Group recorded intercompany commissions and fees from activity with the Specialty Operating Group of $0.6 million; the Specialty Operating Group recorded intercompany commissions and fees revenue from activity with the MainStreet Operating Group and itself of $8.8 million; the MainStreet Operating Group recorded intercompany commissions and fees from activity with the Middle Market and Specialty Operating Groups of less than $0.2 million; and the Medicare Operating Group recorded intercompany commissions and fees from activity with itself of $0.8 million.
Commissions, Employee Compensation and Benefits
The following table sets forth our commissions, employee compensation and benefits by Operating Group and for Corporate and Other by amount and as a percentage of our commissions, employee compensation and benefits:

Commissions, Employee Compensation and Benefits by Operating Group (in thousands, except percentages)
| For the Three Months Ended June 30, |  |  |  | For the Six Months Ended June 30, |  |
| 2022 | 2021 | Variance |  | 2022 | 2021 | Variance
Operating Group | Amount | Percent of Business | Amount | Percent of Business | Amount | % |  | Amount | Percent of Business | Amount | Percent of Business | Amount | %
Middle Market | $ | 92,398 |  | 53 | % | $ | 50,980 |  | 57 | % | $ | 41,418 |  | 81 | % |  | $ | 187,188 |  | 57 | % | $ | 107,722 |  | 60 | % | $ | 79,466 |  | 74 | %
Specialty | 52,861 |  | 31 | % | 22,427 |  | 25 | % | 30,434 |  | 136 | % |  | 87,537 |  | 27 | % | 40,379 |  | 23 | % | 47,158 |  | 117 | %
MainStreet | 17,204 |  | 10 | % | 5,880 |  | 7 | % | 11,324 |  | 193 | % |  | 24,708 |  | 7 | % | 11,026 |  | 6 | % | 13,682 |  | 124 | %
Medicare | 4,777 |  | 3 | % | 3,775 |  | 4 | % | 1,002 |  | 27 | % |  | 12,146 |  | 4 | % | 8,353 |  | 5 | % | 3,793 |  | 45 | %
Corporate and Other | 5,608 |  | 3 | % | 6,003 |  | 7 | % | (395) |  | (7) | % |  | 15,019 |  | 5 | % | 10,960 |  | 6 | % | 4,059 |  | 37 | %
| $ | 172,848 |  |  | $ | 89,065 |  |  | $ | 83,783 |  |  |  | $ | 326,598 |  |  | $ | 178,440 |  |  | $ | 148,158 |  |

Commissions, employee compensation and benefits expenses increased across all Operating Groups for the second quarter of 2022 as compared to the same period of 2021. The Partnership Contribution accounted for $26.6 million, $10.1 million, $8.5 million and $0.2 million of the increase to commissions, employee compensation and benefits expenses in the Middle Market, Specialty, MainStreet and Medicare Operating Groups, respectively. Commissions, employee compensation and benefits expenses also increased across all Operating Groups as a result of continued investments in hiring for our Growth Services team to support our growth, which costs are primarily allocated among the Operating Groups, and continued investment in sales and service talent.
Commissions, employee compensation and benefits expenses increased across all Operating Groups for the first half of 2022 as compared to the same period of 2021. The Partnership Contribution accounted for $53.1 million, $20.0 million, $8.5 million and $0.7 million of the increase to commissions, employee compensation and benefits expenses in the Middle Market, Specialty, MainStreet and Medicare Operating Groups, respectively. Commissions, employee compensation and benefits expenses also increased across all Operating Groups as a result of continued investments in hiring for our Growth Services team to support our growth, which costs are primarily allocated among the Operating Groups, and continued investment in sales and service talent.
37

Commissions, employee compensation and benefits expenses for Corporate and Other increased $4.1 million for the first half of 2022 as compared to the same period of 2021 as a result of continued investments in hiring to support our growth and additional share-based compensation expense.
Other Operating Expenses
The following table sets forth our other operating expenses by Operating Group and for Corporate and Other by amount and as a percentage of our other operating expenses:

Other Operating Expenses by Operating Group (in thousands, except percentages)
| For the Three Months Ended June 30, |  |  |  | For the Six Months Ended June 30, |  |
| 2022 | 2021 | Variance |  | 2022 | 2021 | Variance
Operating Group | Amount | Percent of Business | Amount | Percent of Business | Amount | % |  | Amount | Percent of Business | Amount | Percent of Business | Amount | %
Middle Market | $ | 18,064 |  | 44 | % | $ | 10,230 |  | 52 | % | $ | 7,834 |  | 77 | % |  | $ | 32,573 |  | 42 | % | $ | 17,830 |  | 49 | % | $ | 14,743 |  | 83 | %
Specialty | 7,773 |  | 19 | % | 2,176 |  | 11 | % | 5,597 |  | 257 | % |  | 13,153 |  | 17 | % | 4,043 |  | 11 | % | 9,110 |  | 225 | %
MainStreet | 4,541 |  | 11 | % | 1,260 |  | 6 | % | 3,281 |  | 260 | % |  | 7,547 |  | 10 | % | 2,295 |  | 6 | % | 5,252 |  | 229 | %
Medicare | 1,577 |  | 4 | % | 1,115 |  | 6 | % | 462 |  | 41 | % |  | 2,719 |  | 4 | % | 2,487 |  | 7 | % | 232 |  | 9 | %
Corporate and Other | 8,815 |  | 22 | % | 4,756 |  | 24 | % | 4,059 |  | 85 | % |  | 21,220 |  | 27 | % | 9,757 |  | 27 | % | 11,463 |  | 117 | %
| $ | 40,770 |  |  | $ | 19,537 |  |  | $ | 21,233 |  |  |  | $ | 77,212 |  |  | $ | 36,412 |  |  | $ | 40,800 |  |

Other operating expenses for our Middle Market Operating Group increased $7.8 million for the second quarter of 2022 as compared to the same period of 2021 driven by higher costs for dues and subscriptions of $3.0 million, rent expense of $2.5 million, travel and entertainment of $1.4 million, colleague education and welfare of $1.3 million and professional fees of $1.1 million, offset in part by a decrease in consulting fees of $2.2 million. Other operating expenses for our Specialty Operating Group increased $5.6 million for the second quarter of 2022 as compared to the same period of 2021 driven by higher costs for professional fees of $1.2 million, dues and subscriptions of $0.9 million, rent expense and colleague education and welfare of $0.4 million each, and travel and entertainment, recruiting, and advertising and marketing of $0.3 million each. Other operating expenses for our MainStreet Operating Group increased $3.3 million for the second quarter of 2022 as compared to the same period of 2021 driven by higher rent expense of $1.0 million, professional fees and advertising and marketing of $0.4 million each, and recruiting and dues and subscriptions of $0.3 million each. Other operating expenses for our Medicare Operating Group increased $0.5 million for the second quarter of 2022 as compared to the same period of 2021 driven by higher professional fees of $0.4 million and advertising and marketing of $0.2 million, offset in part by a decrease in consulting fees of $0.3 million. The increases in our operating costs are related to our growth, both organically and through Partnerships, during the previous twelve months.
Other operating expenses for our Middle Market Operating Group increased $14.7 million for the first half of 2022 as compared to the same period of 2021 driven by higher costs for rent expense of $3.9 million, dues and subscriptions of $3.7 million, travel and entertainment of $2.7 million, professional fees of $2.1 million, colleague education and welfare of $1.8 million and advertising and marketing of $1.0 million, offset in part by a decrease in consulting fees of $2.3 million. Other operating expenses for our Specialty Operating Group increased $9.1 million for the first half of 2022 as compared to the same period of 2021 driven by higher costs for professional fees of $2.0 million, dues and subscriptions of $1.1 million, advertising and marketing of $0.7 million, and rent expense, colleague education and welfare, licenses and taxes, and travel and entertainment of $0.6 million each. Other operating expenses for our MainStreet Operating Group increased $5.3 million for the first half of 2022 as compared to the same period of 2021 driven by higher professional fees of $1.7 million, rent expense of $1.1 million, advertising and marketing of $0.5 million and dues and subscriptions of $0.4 million. Other operating expenses for our Medicare Operating Group increased $0.2 million for the first half of 2022 as compared to the same period of 2021 driven by higher costs for advertising and marketing of $0.3 million and professional fees of $0.2 million, offset in part by a decrease in consulting fees of $0.4 million. The increases in our operating costs are related to our growth, both organically and through Partnerships, during the previous twelve months.
Other operating expenses in Corporate and Other increased $4.1 million for the second quarter of 2022 as compared to the same period of 2021 due to higher costs for professional fees of $3.6 million, colleague education and welfare of $1.3 million and repairs and maintenance of $1.0 million. These increases were partially offset by a decrease in consulting fees of $3.7 million.
38

Other operating expenses in Corporate and Other increased $11.5 million for the first half of 2022 as compared to the same period of 2021 due to higher costs for professional fees of $5.5 million, colleague education and welfare of $1.9 million, dues and subscriptions and licenses and taxes of $1.6 million each, repairs and maintenance of $1.4 million and recruiting expense and travel and entertainment of $1.1 million each. These increases were partially offset by a decrease in consulting fees of $3.0 million.
Amortization Expense
The following table sets forth our amortization by Operating Group and for Corporate and Other by amount and as a percentage of our amortization:

Amortization Expense by Operating Group (in thousands, except percentages)
| For the Three Months Ended June 30, |  |  |  | For the Six Months Ended June 30, |  |
| 2022 | 2021 | Variance |  | 2022 | 2021 | Variance
Operating Group | Amount | Percent of Business | Amount | Percent of Business | Amount | % |  | Amount | Percent of Business | Amount | Percent of Business | Amount | %
Middle Market | $ | 12,536 |  | 65 | % | $ | 7,462 |  | 69 | % | $ | 5,074 |  | 68 | % |  | $ | 25,084 |  | 68 | % | $ | 14,911 |  | 70 | % | $ | 10,173 |  | 68 | %
Specialty | 4,221 |  | 22 | % | 2,418 |  | 23 | % | 1,803 |  | 75 | % |  | 8,414 |  | 23 | % | 4,727 |  | 22 | % | 3,687 |  | 78 | %
MainStreet | 2,013 |  | 11 | % | 410 |  | 4 | % | 1,603 |  | n/m |  | 2,406 |  | 7 | % | 826 |  | 4 | % | 1,580 |  | 191 | %
Medicare | 398 |  | 2 | % | 451 |  | 4 | % | (53) |  | (12) | % |  | 825 |  | 2 | % | 814 |  | 4 | % | 11 |  | 1 | %
Corporate and Other | 2 |  | — | % | 1 |  | — | % | 1 |  | — | % |  | 3 |  | — | % | 1 |  | — | % | 2 |  | — | %
| $ | 19,170 |  |  | $ | 10,742 |  |  | $ | 8,428 |  |  |  | $ | 36,732 |  |  | $ | 21,279 |  |  | $ | 15,453 |  |

__________
n/m not meaningful
Amortization expense increased for our Middle Market, Specialty and MainStreet Operating Groups for the three and six months ended June 30, 2022 as compared to the same period of 2021 driven by amortization related to Partners acquired over the past twelve months. Amortization expense for the Medicare Operating Group was relatively flat.
Change in Fair Value of Contingent Consideration
The following table sets forth our change in fair value of contingent consideration by Operating Group by amount and as a percentage of our change in fair value of contingent consideration:

Change in Fair Value of Contingent Consideration by Operating Group (in thousands, except percentages)
| For the Three Months Ended June 30, |  |  |  | For the Six Months Ended June 30, |  |
| 2022 | 2021 | Variance |  | 2022 | 2021 | Variance
Operating Group | Amount | Percent of Business | Amount | Percent of Business | Amount | % |  | Amount | Percent of Business | Amount | Percent of Business | Amount | %
Middle Market | $ | (24,957) |  | 93 | % | $ | 12,569 |  | 94 | % | $ | (37,526) |  | n/m |  | $ | (31,012) |  | 95 | % | $ | 9,046 |  | 77 | % | $ | (40,058) |  | n/m
Specialty | (1,714) |  | 6 | % | 1,448 |  | 11 | % | (3,162) |  | (218) | % |  | (1,897) |  | 6 | % | 2,483 |  | 21 | % | (4,380) |  | (176) | %
MainStreet | 258 |  | (1) | % | (19) |  | — | % | 277 |  | n/m |  | 438 |  | (1) | % | 174 |  | 1 | % | 264 |  | 152 | %
Medicare | (459) |  | 2 | % | (673) |  | (5) | % | 214 |  | (32) | % |  | (33) |  | — | % | 119 |  | 1 | % | (152) |  | (128) | %
| $ | (26,872) |  |  | $ | 13,325 |  |  | $ | (40,197) |  |  |  | $ | (32,504) |  |  | $ | 11,822 |  |  | $ | (44,326) |  |

__________
n/m not meaningful
The change in fair value of contingent consideration for 2022 was impacted by high market volatility, rising interest rates and changes in growth trends of certain partners, which resulted in the reduction of contingent earnout consideration values.
39

LIQUIDITY AND CAPITAL RESOURCES
Our primary liquidity needs for the next twelve months will include cash to (i) provide capital to facilitate the organic growth of our business and to fund future Partnerships, (ii) pay operating expenses, including cash compensation to our employees and expenses related to being a public company, (iii) make payments under the Tax Receivable Agreement, (iv) pay interest and principal due on borrowings under the JPM Credit Agreement, (v) pay contingent earnout liabilities and (vi) pay taxes. We have historically financed our operations and funded our debt service through the sale of our insurance products and services. In addition, we have financed significant cash needs to fund growth through the acquisition of Partners through debt and equity financing.
At June 30, 2022, our cash and cash equivalents were $183.4 million. We believe that our cash and cash equivalents, cash flow from operations and available borrowings under the JPM Credit Agreement will be sufficient to fund our working capital and meet our commitments for the next twelve months and beyond. However, we expect that we will require additional funding to continue to execute on our Partnership strategy. Such funding could include the incurrence of additional debt and the issuance of equity. Additional funds may not be available on a timely basis, on favorable terms, or at all, and such funds, if raised, may not be sufficient to enable us to continue to implement our long-term Partnership strategy. If we are not able to raise funds when needed, we could be forced to delay or reduce the number of Partnerships that we complete.
JPM Credit Agreement
As of December 31, 2021, our JPM Credit Agreement provided for senior secured credit facilities in an aggregate principal amount of $1.325 billion, which consisted of (i) a term loan facility in the principal amount of $850.0 million maturing in 2027 (the “Term Loan B”) and (ii) a revolving credit facility with commitments in an aggregate principal amount of $475.0 million maturing in 2025 (the “Revolving Facility”).
On March 28, 2022, the Company entered into Amendment No. 5 to the JPM Credit Agreement, under which (i) the aggregate principal amount of the Revolving Facility was increased from $475.0 million to $600.0 million and (ii) the interest rate on the Revolving Facility changed to the SOFR, plus a credit spread adjustment of 10 basis points (“bps”), plus an amount between 200 bps and 300 bps based on the total net leverage ratio, (iii) the total net leverage ratio covenant increased to 7.0x consolidated EBITDA and (iv) the maturity of the Revolving Facility was extended to April 1, 2027. The other terms of the Revolving Facility and the terms of the Term Loan B remained unchanged.
The Term Loan B bears interest at LIBOR plus 350 bps, subject to a LIBOR floor of 50 bps. The applicable interest rate on the Term Loan B at June 30, 2022 was 4.69%. Borrowings under the Revolving Facility accrue interest at SOFR plus 210 bps to SOFR plus 310 bps based on total net leverage ratio. BRP will pay a letter of credit fee equal to the margin then in effect with respect to SOFR loans under the Revolving Facility multiplied by the daily amount available to be drawn under any letter of credit, a fronting fee and any customary documentary and processing charges for any letter of credit issued under the JPM Credit Agreement. The outstanding borrowings on the Revolving Facility of $525.0 million had an applicable interest rate of 4.50% at June 30, 2022. The Revolving Facility is also subject to a commitment fee of 0.40% on the unused capacity at June 30, 2022.
The Revolving Facility and the Term Loan B are collateralized by a first priority lien on substantially all the assets of BRP, including a pledge of all equity securities of certain of its subsidiaries. The JPM Credit Agreement contains covenants that, among other things, restrict our ability to make certain restricted payments, incur additional debt, engage in certain asset sales, mergers, acquisitions or similar transactions, create liens on assets, engage in certain transactions with affiliates, change our business, make certain investments or restrict BRP’s ability to make dividends or other distributions to BRP Group. In addition, the JPM Credit Agreement contains financial covenants requiring us to maintain our Total First Lien Net Leverage Ratio (as defined in the JPM Credit Agreement) at or below 7.00 to 1.00.
40

Contractual Obligations and Commitments
The following table represents our contractual obligations, aggregated by type, at June 30, 2022:

| Payments Due by Period
(in thousands) | Total |  | Less than 1 year |  | 1-3 years |  | 3-5 years |  | More than 5 years
Operating leases(1) | $ | 102,590 |  |  | $ | 16,010 |  |  | $ | 31,485 |  |  | $ | 26,951 |  |  | $ | 28,144 |
Debt obligations payable(2) | 1,683,130 |  |  | 71,453 |  |  | 141,708 |  |  | 659,284 |  |  | 810,685 |
Maximum future acquisition contingency payments(3) | 980,944 |  |  | 154,458 |  |  | 816,486 |  |  | 10,000 |  |  | — |
Total | $ | 2,766,664 |  |  | $ | 241,921 |  |  | $ | 989,679 |  |  | $ | 696,235 |  |  | $ | 838,829 |

__________
(1) The Company leases facilities and equipment under noncancelable operating leases. Rent expense was $12.8 million and $7.4 million for the six months ended June 30, 2022 and 2021, respectively.
(2) Represents scheduled debt obligations and estimated interest payments under the JPM Credit Agreement.
(3) Includes $210.0 million of current and non-current estimated contingent earnout liabilities at June 30, 2022.
Tax Receivable Agreement
We expect to obtain an increase in our share of our tax basis of the assets when BRP’s LLC Units are redeemed or exchanged for shares of BRP Group’s Class A common stock. This increase in tax basis may have the effect of reducing the future amounts paid to various tax authorities. The increase in tax basis may also decrease gains (or increase losses) on future dispositions of certain capital assets to the extent tax basis is allocated to those capital assets.
We have a Tax Receivable Agreement that provides for the payment by us to the parties to the Tax Receivable Agreement of 85% of the amount of cash savings, if any, in U.S. federal, state and local income tax or franchise tax that we actually realize as a result of (i) any increase in tax basis in BRP Group’s assets and (ii) tax benefits related to imputed interest deemed arising as a result of payments made under the tax receivable agreement.
During the six months ended June 30, 2022, we redeemed 874,187 LLC Units of BRP on a one-for-one basis for shares of Class A common stock and cancelled the corresponding shares of Class B common stock, which triggered an increase in BRP Group’s tax basis but did not result in a tax benefit to the LLC Unit holders.
SOURCES AND USES OF CASH
The following table summarizes our cash flows from operating, investing and financing activities for the periods indicated:

| For the Six Months Ended June 30, |  |
(in thousands) | 2022 |  | 2021 |  | Variance
Net cash provided by (used in) operating activities | $ | (4,641) |  |  | $ | 49,419 |  |  | $ | (54,060) |
Net cash used in investing activities | (389,895) |  |  | (27,607) |  |  | (362,288) |
Net cash provided by financing activities | 450,730 |  |  | 112,150 |  |  | 338,580 |
Net increase in cash and cash equivalents and restricted cash | 56,194 |  |  | 133,962 |  |  | (77,768) |
Cash and cash equivalents and restricted cash at beginning of period | 227,737 |  |  | 142,022 |  |  | 85,715 |
Cash and cash equivalents and restricted cash at end of period | $ | 283,931 |  |  | $ | 275,984 |  |  | $ | 7,947 |

Operating Activities
The primary sources and uses of cash for operating activities are net income adjusted for non-cash items and changes in assets and liabilities. Net cash provided by operating activities decreased $54.1 million for the first half of 2022 as compared to the same period of 2021 driven by a decrease in cash relating to payments of contingent earnout consideration and related party notes payable. Payment of contingent earnout consideration in excess of the liability recognized at the acquisition date of $47.8 million is captured as an operating cash flow during 2022 and is reflective of Partnerships that have outperformed on our platform since the date of Partnership. Cash also decreased from a higher balance in premiums, commissions and fees receivable of $26.0 million resulting from revenue growth and the timing of revenue recognition under direct bill policies in employee benefits for which payment is received monthly through the duration of the year. These decreases were partially offset by an increase in cash from a higher balance in accounts payable, accrued expenses and other current liabilities of $16.3 million related, in part, to the aforementioned revenue growth and higher premiums receivable balance.
41

Investing Activities
The primary sources and uses of cash for investing activities relate to cash consideration paid to fund Partnerships and other investments, as well as capital expenditures. Net cash used in investing activities increased $362.3 million for the first half of 2022 as compared to the same period of 2021 driven by an increase in cash consideration paid for Partnership activity of $354.8 million due to our having completed our largest Partnership to date during the second quarter of 2022.
Financing Activities
The primary sources and uses of cash for financing activities relate to the issuance of our Class A common stock, borrowings from and repayment to our credit agreements, payment of debt issuance costs, payment of contingent earnout consideration, and other equity transactions. Net cash provided by financing activities increased $338.6 million for the first half of 2022 as compared to the same period of 2021 primarily as a result of an increase in net borrowings on our credit facilities of $368.8 million, offset in part by an increase in payments of contingent earnout consideration up to the amount of purchase price accrual of $42.4 million.
CRITICAL ACCOUNTING ESTIMATES
In preparing our financial statements in accordance with GAAP, we are required to make estimates and assumptions that affect the amounts of assets, liabilities, revenue, expenses, disclosure of contingent assets and liabilities and accompanying disclosures. We evaluate our estimates and assumptions on an ongoing basis. These estimates are based on historical experience and various other assumptions that we believe to be reasonable under the circumstances; although, actual results may differ from these estimates and assumptions. To the extent that there are differences between our estimates and actual results, our financial condition, results of operations and cash flows will be affected.
There have been no material changes in our critical accounting policies during the three months ended June 30, 2022 as compared to those disclosed in the Critical Accounting Estimates section under Management’s Discussion and Analysis of Financial Condition and Results of Operations of our Annual Report on Form 10-K filed with the SEC on March 1, 2022.
RECENT ACCOUNTING PRONOUNCEMENTS
Please refer to Note 1 to our condensed consolidated financial statements included in Item 1. Financial Statements of this report for a discussion of recent accounting pronouncements that may impact us.
ITEM 3. QUALITATIVE AND QUANTITATIVE DISCLOSURES ABOUT MARKET RISK
Market risk is the potential loss arising from adverse changes in market rates and prices, such as premium amounts, interest rates and equity prices. We are exposed to market risk through our investments and borrowings under the JPM Credit Agreement. We use derivative instruments to mitigate our risk related to the effect of rising interest rates on our cash flows. However, we do not use derivative instruments for trading or speculative purposes.
Our invested assets are held primarily as cash and cash equivalents, restricted cash, certificates of deposit, U.S. treasury securities and professionally managed short duration fixed income funds. These investments are subject to interest rate risk. The fair values of our invested assets at June 30, 2022 and December 31, 2021 approximated their respective carrying values due to their short-term duration and therefore, such market risk is not considered to be material.
Insurance premium pricing has historically been cyclical, based on the underwriting capacity of the insurance industry and economic conditions. External events, such as terrorist attacks, man-made and natural disasters, can also have significant impacts on the insurance market. We use the terms ‘‘soft market’’ and ‘‘hard market’’ to describe the business cycles experienced by the industry. A soft market is an insurance market characterized by a period of declining premium rates, which can negatively affect commissions earned by insurance agents. A hard market is an insurance market characterized by a period of rising premium rates, which, absent other changes, can positively affect commissions earned by insurance agents.
We do not actively invest or trade in equity securities. In addition, we generally dispose of any significant equity securities held by Partners received in conjunction with an acquisition shortly after the acquisition date.
42

At June 30, 2022, we had $842.4 million and $525.0 million of borrowings outstanding under the Term Loan B and the Revolver, respectively. These borrowings bear interest on a floating basis tied to either the prime rate or one of various other variable rates as defined in the JPM Credit Agreement. The variable rate currently in effect for the Term Loan B is LIBOR and the variable rate currently in effect for the Revolver is SOFR.
We have entered into interest rate cap agreements to limit the potential impact of interest rate changes on cash flows. One of these agreements expired during March 2022 and three others were sold during May 2022, increasing our overall exposure to rising interest rates. The interest rate cap agreement in place at June 30, 2022 mitigates the interest rate volatility on $300.0 million of debt to a maximum of 1.50%. Taking the interest rate cap agreement into consideration, an increase of 100 basis points in LIBOR and SOFR at June 30, 2022 would have increased our annual interest expense for the JPM Credit Agreement by $11.6 million.
ITEM 4. CONTROLS AND PROCEDURES
Evaluation of Disclosure Controls and Procedures
Under the supervision and with the participation of management, including the Chief Executive Officer and Chief Financial Officer, we conducted an evaluation of the effectiveness of our disclosure controls and procedures as defined in Rules 13a-15(e) and 15d-15(e) under the Exchange Act as of the end of the period covered by this Quarterly Report on Form 10-Q. The term “disclosure controls and procedures,” as defined in Rules 13a-15(e) and 15d-15(e) under the Exchange Act, means controls and other procedures of a company that are designed to ensure that information required to be disclosed by a company in the reports that it files or submits under the Exchange Act is recorded, processed, summarized and reported within the time periods specified in the SEC’s rules and forms. Disclosure controls and procedures include, without limitation, controls and procedures designed to ensure that information required to be disclosed by a company in the reports that it files or submits under the Exchange Act is accumulated and communicated to the company’s management, including its principal executive and principal financial officers, as appropriate to allow timely decisions regarding required disclosure. Management recognizes that any controls and procedures, no matter how well designed and operated, can provide only reasonable assurance of achieving their objectives and management necessarily applies its judgment in evaluating the cost-benefit relationship of possible controls and procedures. Based on this evaluation, our Chief Executive Officer and Chief Financial Officer have concluded that, because of the material weaknesses in our internal control over financial reporting described in our Annual Report on Form 10-K for the year ended December 31, 2021, our disclosure controls and procedures were not effective as of June 30, 2022.
Notwithstanding the material weaknesses in internal control over financial reporting, our management concluded that our condensed consolidated financial statements included in this Quarterly Report on Form 10-Q, when read with the notes thereto, present fairly, in all material respects, our financial position, results of operations and cash flows for the periods presented in conformity with GAAP.
We completed 13 Partnerships for an aggregate purchase price of $1.4 billion during the twelve months ended June 30, 2022. Guidance from the staff of the Securities and Exchange Commission provides that the staff will not take exception to companies that exclude acquisitions from their assessment of internal control over financial reporting during the first year of an acquisition, and our management has elected to exclude all 13 Partnerships from our assessment as of June 30, 2022. The 13 Partnerships represent approximately 9% of our consolidated total assets (the calculation excludes the goodwill and intangible assets of those acquired entities as the goodwill and intangible assets were subject to management’s assessment of internal control over financial reporting) and approximately 30% of total revenues as of and for the six months ended June 30, 2022, respectively.
Changes in Internal Control over Financial Reporting
Except with respect to our ongoing remediation efforts with respect to the aforementioned material weaknesses, there were no changes in our internal control over financial reporting that occurred during the quarter-ended June 30, 2022 that materially affected, or that are reasonably likely to materially affect our internal control over financial reporting.
PART II. OTHER INFORMATION
ITEM 1. LEGAL PROCEEDINGS
We are involved in various claims and legal actions arising in the ordinary course of business. In the opinion of management, the ultimate disposition of these matters will not have a material adverse effect on our consolidated financial position, results of operations or liquidity.
43

ITEM 1A. RISK FACTORS
See the risk factors outlined under Part I, Item 1A. Risk Factors in our Annual Report on Form 10-K filed with the SEC on March 1, 2022.
ITEM 2. UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS
Sales of Unregistered Securities
The following list sets forth information regarding all unregistered securities sold or issued by us since March 31, 2022. No underwriters were involved in these sales. There was no general solicitation of investors or advertising, and we did not pay or give, directly or indirectly, any commission or other remuneration, in connection with the offering of these securities. In the transactions described below, the recipients of the securities represented their intention to acquire the securities for investment only and not with a view to or for sale in connection with any distribution thereof, and appropriate legends were affixed to the securities issued in these transactions.
•On June 3, 2022, as partial consideration for the acquisition by the Company of substantially all of the assets of Venture Captive Management, LLC, BRP Group issued 97,156 shares of Class A common stock.
•On August 1, 2022, as partial consideration for the acquisition by the Company of substantially all of the assets of Health Plans & Benefits Agency, LLC, BRP Group issued 129,182 shares of Class A common stock.
The securities described above were issued to a limited number of investors, all of which had sufficient knowledge and experience in financial and business matters to make them capable of evaluating the merits and risks of the prospective investment, and for nominal consideration. The offer, sale and issuance of the securities described above were deemed to be exempt from registration under the Securities Act in reliance upon Section 4(a)(2) of the Securities Act as transactions by an issuer not involving any public offering.
Issuer Purchases of Equity Securities
The following table provides information about our repurchase of shares of our Class A common stock during the three months ended June 30, 2022:

| Total Number of Shares Purchased(1) |  | Average Price Paid per Share |  | Total Number of Shares Purchased as Part of Publicly Announced Plans or Programs |  | Maximum Value that may yet be Purchased under the Plans or Programs
April 1, 2022 to April 30, 2022 | 46,711 |  |  | $ | 27.77 |  |  | — |  |  | $ | — |
May 1, 2022 to May 31, 2022 | — |  |  | — |  |  | — |  |  | — |
June 1, 2022 to June 30, 2022 | — |  |  | — |  |  | — |  |  | — |
Total | 46,711 |  |  | $ | 27.77 |  |  | — |  |  | $ | — |

__________
(1) We purchased 46,711 shares during the three months ended June 30, 2022, which were acquired from our employees to cover required tax withholding on the vesting of shares granted under the BRP Group, Inc. Omnibus Incentive Plan.
ITEM 3. DEFAULTS UPON SENIOR SECURITIES
None.
ITEM 4. MINE SAFETY DISCLOSURES
Not applicable.
ITEM 5. OTHER INFORMATION
None.
44

ITEM 6. EXHIBITS
The following exhibits are filed as a part of this Quarterly Report on Form 10-Q:

Exhibit No. |  | Description of Exhibit
31.1* |  | Certification of the Registrant’s Chief Executive Officer pursuant to Rule 13a-14 of the Securities Exchange Act of 1934
31.2* |  | Certification of the Registrant’s Chief Financial Officer pursuant to Rule 13a-14 of the Securities Exchange Act of 1934
32** |  | Certification of the Registrant’s Chief Executive Officer and Chief Financial Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002
101.INS* |  | XBRL Instance Document
101.SCH* |  | XBRL Taxonomy Extension Schema Document
101.CAL* |  | XBRL Taxonomy Extension Calculation Linkbase Document
101.DEF* |  | XBRL Taxonomy Extension Definition Linkbase Document
101.LAB* |  | XBRL Taxonomy Extension Label Linkbase Document
101.PRE* |  | XBRL Taxonomy Extension Presentation Linkbase Document
104* |  | Cover Page Interactive Data File (formatted in inline XBRL and included in Exhibit 101)

__________
* Filed herewith
** Furnished herewith and as such are deemed not “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended, nor shall they be deemed incorporated by reference in any filing under the Securities Act of 1933, except as shall be expressly set forth by specific reference in such filing.
45

SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

|  | BRP GROUP, INC.
Date: August 9, 2022 | By: | /s/ Trevor L. Baldwin
|  | Trevor L. Baldwin
|  | Chief Executive Officer
Date: August 9, 2022 | By: | /s/ Bradford L. Hale
|  | Bradford L. Hale
|  | Chief Financial Officer

46